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ABSTRACT
AUDREY ROSE VERDE: STRUCTURAL ABNORMALITIES WITHIN THE
EPISODIC PROSPECTION AND DECISION MAKING CIRCUITRY IN
CIGARETTE SMOKERS: A DTI AND SMRI ANALYSIS.
(Under the direction of Charlotte Boettiger and Martin Styner)
Smokers characteristically show a heightened tendency to select smaller, sooner over
larger, delayed rewards, and the neurobiology of such decision−making is beginning to
come to light. For instance, recent studies in healthy people show that engaging episodic
prospection during such decision−making can reduce impulsive choices, and that this
effect is mediated by enhanced functional connectivity between medial temporal lobe
regions implicated in episodic prospection and frontal areas. Through this study we
sought to determine if there are any structural differences between cigarette smokers
and non−smokers in the episodic prospection and decision making circuitry through the
use of diffusion tensor imaging (DTI) and structural MRI (sMRI) analysis. Further, we
investigated whether there were any structural changes in this circuitry within smokers
that correlated with measurements of cigarette consumption (cigarettes per day, breath
carbon monoxide), and addiction severity (cigarette dependence scale). Specifically we
studied the white matter (WM) tracts the cingulum, fornix, and uncinate, and the grey
matter (GM) regions that these tracts connect, namely regions of the medial temporal
lobe and the prefrontal cortex. Our hypotheses were that smokers would have de-
creased WM structural integrity in the tracts bilaterally compared to nonsmokers, and
that the brain regions served by these tracts would have decreased volume and thick-
ness in smokers compared to non−smokers. Within smokers, we hypothesized that
with increasing cigarette consumption and addiction severity there would be decreased
iii
WM integrity, and decreased regional GM volume and thickness. We acquired diffu-
sion weighted and anatomical MR images from nonsmokers (n=15) and smokers (n=10
(11 for sMRI)), aged 19−40 years old. We developed and utilized a novel framework
for DTI analysis, the UNC−Utah NA−MIC Framework for DTI Fiber Tract Analysis.
We found smokers to have decreased WM integrity in the fornix crus, and decreased
hippocampal volume compared to nonsmokers. Looking just within smokers, we found
positive correlations between WM integrity and measurements of cigarette consump-
tion and addiction severity for the fornix and cingulum. GM analysis though showed
negative correlations between these same smoking indices and measurements of cortical
thickness and volume in the inferior frontal gyrus, lateral orbitofrontal cortex, cingu-
late, and amygdala. Together these results demonstrate that the circuitry for episodic
prospection, decision making, and cognitive control are altered in cigarette smokers and
that the structural aberration correlates with measures of cigarette consumption and
dependence.
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this without your love and support.
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CHAPTER 1
INTRODUCTION
1.1 Cigarettes − a global epidemic
This year marks the 50−year anniversary of the first US public health warning
from the Surgeon General stating that cigarettes play a causative role in cancer and
disease. Since then research has continued to uncover the role cigarettes play in causing
disease and death. However, even after half a century of research and public health
warnings, one billion people continue to smoke cigarettes worldwide [1]. Cigarettes are
the number one preventable cause of death and disease, killing more than five million
people worldwide each year [2]. One person dies from a tobacco related disease every
six seconds, accounting for one in ten deaths worldwide [1] and one in five deaths in the
US [3]. More deaths are caused by cigarettes than alcohol use, illegal drug use, HIV,
motor vehicle accidents, murders, and suicides combined [4; 3; 5]. Ultimately, half of
smokers will die due to a tobacco related illness [6].
While cigarette smoking has dropped in the US from 42% of adults in 1964 to 18%
in 2012, the consumption of tobacco products is increasing worldwide [7; 1]. Tobacco
is the only legal drug that the act of consumption affects not only the smoker, but
everyone around them. Six hundred thousand deaths each year worldwide are due to
second hand smoke exposure alone. At the current increase in use, it is anticipated that
tobacco will kill more than a billion people in just the 21st century [1]. It is imperative
that we as a global community do something to prevent further people from starting
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to smoke cigarettes, and to help those who are currently addicted to quit.
Of those that try cigarettes once, 32% will progress to dependence. This experiment
to addiction ratio for cigarettes is higher than that of heroin (23%), cocaine (17%), or
alcohol (15%), indicating the habit−forming power of cigarettes [8]. Of current smokers,
approximately 70% report wishing to quit and 50% report a past year quit attempt,
but only 5% successfully abstain at one year out from their quit date [9; 10]. With
the use of available therapies quit success can be raised to 30% [11], however, 95% of
smokers will not seek help in their quit attempt. While new, more effective therapies
are needed, we also need to begin to understand why currently available therapies are
underused. Further understanding the neurobiology of cigarette addiction may help to
shed light on both of these pressing issues.
DSM-V 
Tobacco Use Disorder 
maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by 
2 (or more) of the following, occurring within a 12-month period: 
1.  Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home 
2.  Recurrent substance use in situations in which it is physically hazardous 
3.  Continued substance use despite having persistent or recurrent social or interpersonal problems caused or 
exacerbated by the effects of the substance 
4.  Tolerance, as defined by either of the following: a) need for markedly increased amounts of the substance 
to achieve intoxication or desired effect b) markedly diminished effect with continued use of the same 
amount of the substance 
5.  Withdrawal, as manifested by either of the following: a) the characteristic withdrawal syndrome for the 
substance; b) the same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms 
6.  The substance is often taken in larger amounts or over a longer period than was intended 
7.  There is a persistent desire or unsuccessful efforts to cut down or control substance use 
8.  A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover 
from its effects 
9.  Important social, occupational, or recreational activities are given up or reduced because of substance use 
10.  The substance use is continued despite knowledge of having a persistent or recurrent physical or 
psychological problem that is likely to have been caused or exacerbated by the substance 
11.  Craving or a strong desire or urge to use a specific substance 
Table 1.1: Tobacco use disorder diagnosis criteria from the DSM−V. Adapted from [12]
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1.2 Diagnosis and treatment of cigarette dependence
The extremely low success rate of smoking cessation attempts may in part be due to
the fact that cigarettes are both physiologically and psychologically addictive. Phys-
iologic or somatic addiction refers to the development of tolerance and withdrawal
symptoms. Psychological addiction refers to changes in behavior characterized by com-
pulsive use of the substance, craving, addiction memory, loss of control, and continuing
to use the substance despite negative consequences and the desire to quit [12]. While
the physical symptoms of withdrawal will cease after a few weeks, the psychological
symptoms of addiction such as craving and addiction memory can last a lifetime. It is
this mental aspect of addiction that leads many to relapse.
The diagnosis of cigarette dependence is made using clinical criteria from the newest
version of the Diagnosis and Statistical Manual of Mental Disorders (DSM). In the
DSM−V, the diagnosis terminology was changed from a two stepped Nicotine Abuse
and Nicotine Dependence, to just Tobacco Use Disorder. Further, the criteria for diag-
nosis were changed to now only require two or more symptoms within the past twelve
months from a list of 11 criteria as seen in Table 1.1. Notably, the new criteria list
includes craving, as much research has centered on this aspect of cigarette addiction
and how it relates to relapse.
Cigarette dependence is a chronic relapsing disorder that often requires multiple quit
attempts to succeed [12]. As most cigarette smokers start as teenagers, the majority of
successful quit attempts do not occur until age 40 [13]. However, quit rates can improve
through the implementation of several available tools for cessation. First, physicians
of all specialties can make a significant difference in quit rates by just screening for
tobacco use, assessing willingness to quit, and providing information about available
resources and therapies that can aid in quitting smoking [14]. Identifying smokers that
are considering quitting and providing information on cessation is important, because
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the younger a smoker quits the better their health outcomes [15].
However, most smokers who try to quit prefer to attempt cessation cold turkey
and do not seek out professional help [10; 9]. Unfortunately, this technique results in
a one−year cessation success rate of 5%. Long−term cessation success rates can be
improved through physician assistance and the use of available over the counter and
prescription therapies [9]. Treatments available consist of informational counseling,
cognitive behavioral therapy, nicotine replacement therapy (NRT), and pharmacological
agents.
Today there is broad array of ways to start a quit attempt. Resources are available
online such as smokefree.gov, and by telephone via quit lines like 1−800−Quit Now that
allow patients a way to seek counseling from the safety of their own home [16]. Also,
physicians can provide individual or group cognitive behavioral therapy sessions meant
to create a community of support, construct a quit plan, and to outline strategies
for how to deal with cravings and relapse. While both providing information and
formal therapy improve the chance of successfully quitting, the most benefit comes
from combining these efforts with one or more pharmacological agents for smoking
cessation.
The goal of nicotine replacement therapy is to provide nicotine throughout the day
without the use of cigarettes. Through using NRT options, smokers can wean down of
their number of cigarettes each day without experiencing the main deterrent of quitting,
withdrawal symptoms. NRT comes now in many forms and doses for nicotine: gum,
lozenge, patch, nasal spray, and inhaler. The gum, lozenge, and patch provide slow
release of nicotine meant to help keep the blood concentration of nicotine at the smokers
normal level, while the nasal spray and inhaler are meant to mimic the sharp bolus of
nicotine provided by smoking a cigarette. Quit success rates while using one form of
NRT doubles the quit success rate to 10%, and the success of cessation rises further
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when combining multiple forms of NRT [17; 18]. Effectiveness of NRT options varies
though by BMI, number of cigarettes consumed daily, nicotine metabolism, and sex
[19; 20; 21; 22; 23].
After NRT, other first line pharmacological agents used for the treatment of cigarette
dependence are bupropion and varenicline. Bupropion was first approved for use as an
antidepressant and is thought to be a weak inhibitor of dopamine and norepinephrine
reuptake, although the true therapeutic mechanism is unknown [24]. It has been shown
to be as effective as NRT in aiding smoking cessation [25]. Varenicline is another first
line pharmacological agents for the treatment of nicotine dependence that works as a
partial agonist for the α4β2 nicotinic acetylcholine receptor [26]. As varenicline binds
to the same receptor as does nicotine, varenicline is thought to reduce withdrawal
symptoms, and to also reduce the euphoric effect of nicotine by blocking the receptors,
preventing nicotine from binding [26]. Of the pharmacological agents available, Vareni-
cline has been found to have the best cessation success rates, and treatment outcome
further improves by combining it with NRT [27].
Second line pharmacological agents for smoking cessation are the α2 adrenoreceptor
agonist clonidine, and the tricyclic antidepressant nortriptyline. While both medica-
tions yielded cessation rates similar to NRT and bupropion respectively, the side effect
profile for these two medications makes them rarely prescribed [28; 29]. Other medi-
cations investigated for use in treating cigarette dependence but that have had mixed
results are naltrexone, fluoxetine, mecamylamine, and monoamine oxidase inhibitors
[29; 30; 31].
New efforts have been placed in designing a nicotine vaccine to aid in smoking
cessation. The concept behind the vaccine is to create an immune response to nicotine
so when vaccinated individuals smoke a cigarette, the nicotine would be bound in
the bloodstream, keeping it from reaching the brain, and ultimately preventing the
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rewarding effects of smoking. While the vaccine has shown promising results in small
trials, stage III clinical trials failed to show efficacy [32]. Further work to improve
immune response to the vaccine is ongoing.
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FIGURE 1 | Neuronal nicotinic acetylcholine receptors (nAChRs) are
widely distributed in different brain regions that include the ventral
tegmental area (VTA), nucleus accumbens (NAc), hippocampus,
prefrontal cortex (PFC), and amygdala. Activation of nAChRs in these
brain areas significantly contribute to the rewarding effects of ethanol and
nicotine and play a role in modulating synaptic plasticity. GABAergic (red),
glutamatergic (green), and dopaminergic (blue) connections between these
structures constitute a major neural circuitry underlying addictive disorders.
Much of the NMDAR-dependent plasticity has focused on mech-
anisms responsible for the initial increase in synaptic strength,
however the long-lasting biological effects likely require new pro-
tein synthesis and gene transcription (Lynch, 2004). There are
quantifiable alterations in the morphology of dendrites and den-
dritic spines that accompany LTP (Andersen and Soleng, 1998;
Yuste and Bonhoeffer, 2001; Matsuzaki et al., 2004) and together
these long-lasting changes have been implicated as an essen-
tial mechanism and molecular basis for learning and memory.
Additionally, there are other modulators of plasticity, such as
metabotropic glutamate receptors and endocannabinoids, that
have been discovered and reviewed extensively elsewhere [see
review, Kauer and Malenka (2007)].
Alcohol and tobacco addiction are among the highest causes
of preventable death worldwide (Mokdad et al., 2004) and the
comorbidity of these two substance abuse disorders is striking
(DiFranza and Guerrera, 1990; Batel et al., 1995; Falk et al.,
2006). While the easy availability and low social stigma of alcohol
and cigarettes provides an explanation of their high prevalence
of dual dependence, strong neurobiological evidence suggests a
common link between these two substances (de Fiebre et al.,
1990; Smith et al., 1999; Gould et al., 2001; Marubio et al.,
2003; Tizabi et al., 2007). Neuronal nicotinic acetylcholine recep-
tors (nAChRs) are widely expressed throughout the brain (Gotti
et al., 2007) and are suggested to be the common biological tar-
get of nicotine and ethanol (Tapper et al., 2004; Funk et al.,
2006; Steensland et al., 2007; Bito-Onon et al., 2011). nAChRs
are pentameric ligand-gated ion channels, consisting of various
heteromeric or homomeric combinations of α (α2–α10) and β
(β2–β4) subunits (Albuquerque et al., 2009; Gotti et al., 2009).
Most neuronal nAChRs are heteromeric receptors with just two
binding sites, but some subunits, such as the α7, form functional
homomeric receptors with five binding sites (Changeux, 2009;
Gotti et al., 2009). The most abundant of nAChR subtypes in
the brain are the α4β2∗ (∗indicates the possibility of other sub-
units) followed by the α7; correspondingly, the mRNA of these
subtypes are found throughout the entire brain. The vast regional
distribution and location of nAChRs are thoroughly reported in
the following reviews (Gotti and Clementi, 2004; Gotti et al.,
2007).
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Figure 1.1: Neu on l nicotinic acetylcholine receptors (nAChRs) are widely distributed
in different brain regions that include the ventral tegmental area (VTA), nucleus ac-
cumbens (NAc), hippocampus, prefrontalcortex (PFC), and amygdala. Activation of
nAChRs in these brain areas significantly contribute to the rewarding effects of nico-
tine and play a role in modulating synaptic plasticity. GABAergic (red), glutamatergic
(gre n), and dopam nergic (blue) connections betw en these structures onstitut a
major neural circuitry underlying addictive disorders. Printed with permission from c©
[33]
1.3 Neurobiology of cigarette dependence
While cigarette smoke is composed of over 7000 chemicals, the ingredient identified
to play the main role in the addictive properties of cigarettes is icotine. Nicotine
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is a volatile alkaloid naturally occurring in the tobacco leaf and other plants of the
nightshade family. When the end of a cigarette is lit, the air within the cigarette heats
up volatilizing the nicotine from the dried tobacco leaf. As the air is pulled through
the cigarette towards the smokers mouth the air cools and condenses the nicotine on
to particles of smoke for efficient travel to the lungs. Here nicotines small size and
lipophilic nature allows the alkaloid to pass across the alveolar space to enter the blood
stream and reach the brain in 15−20 seconds after being inhaled [16].
Once in the brain, the partial agonist nicotine binds acetylcholine receptor subtypes
distributed throughout the brain termed nicotinic acetylcholine receptors (nAChRs)
[34; 35]. nAChR are ligand gated ion channels composed of hetero or homo pentameric
combinations of alpha (α 2−10) and beta (β 2−4) subunits [36; 37]. The most common
nAChR in the brain is the high affinity α4(3)β 2(2) heteromeric pentamer, with the next
most prevalent being the low affinity α7(5) homomeric receptor. Receptor subtypes
and functions vary by brain region, cell type, location on the cell, type of stimulus, and
time course of synaptic events (Figure 1.1). Most nAChRs are located on the soma,
perisynaptically, or presynaptically and play a modulatory role in synaptic transmission
[38]. When nicotine binds the nAChR alpha subunits there is a conformational change
in the receptor subunits that allows for the influx of cations (Na2+ and Ca2+) into the
cell. This influx of cations causes the cell to depolarize and to fire an action potential,
causing the release of neurotransmitter [39].
Important for the rewarding aspects of cigarette smoking, nicotine binds the α4β2
and α6 containing nAChRs on the soma of the dopamine (DA) neurons in the posterior
ventral tegmental area (VTA). This causes the VTA DA neurons to release DA in the
nucleus accumbens (NAc), prefrontal cortex (PFC), and hippocampus [33]. Further,
the pattern of DA release changes from tonic to phasic burst firing, rapidly increasing
the concentration of DA in the ventral striatum, PFC, and hippocampus, resulting in
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the euphoric and reinforcing aspect of cigarettes, as well as the formation of addiction
memory [40; 41; 42; 43].
Regulating this release of DA from the VTA DA neurons are inputs from gluta-
matergic, gabaergic, and cholingeric cells from other regions of the brain, and within
the VTA (Figure 1.2). Within the VTA, nicotine binds the presynaptic α4β2 nAChRs
on VTA GABA interneurons and α7 nAChRs on VTA glutamatergic neurons, both of
which take part in regulating dopamine release. The VTA DA neurons receive further
excitatory glutamatergic inputs from the PFC, NAc, amygdala, bed nucleus of stria
terminalis, and pontomesencephalic tegmental area [33]. While the α4β2 receptors
quickly desensitize within seconds, the α6 and α7 receptors continue to exert their ef-
fect on the VTA DA neurons for minutes, leading to long−term plasticity of behavior
and reinforcement of the addiction [44; 45; 46].
After a brief activation by nicotine the α4β2 receptors enter a state of desensitiza-
tion. By continuing to smoke, the continued presence of nicotine keeps these receptors
in a desensitized state. This desensitization causes a scenario where the same drag
from a cigarette does not cause the expected release of dopamine, and is the physical
definition of tolerance. Neurons throughout the brain also respond to this increased
desensitization in the presence of nicotine by creating more nAChRs and by modifying
their subunit composition [47]. The α4(3)β2(2) receptors are replaced by α4(2)β2(3),
that have increased sensitivity to nicotine, therefore causing the release of DA at lower
concentrations of nicotine, but continuing to increase the desensitization period and
thus creating the constant loop of increased tolerance, and physical addiction [48]. At
the same time this upregulation of receptors leads to a larger release in DA, the absence
of which causes craving during nicotine withdrawal.
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FIGURE 2 | Schematic representation of nAChR subtypes and circuit
function in the mesolimbic dopaminergic system. (A) Pyramidal cells in
layer V of the PFC lack nAChRs but their activity is modulated by excitatory
and inhibitory neurons that do express them. There are two types of
GABAergic interneurons, fast spiking and non-fast spiking, with only the latter
bearing nAChRs (α7 and α4β2∗ ). Distinct populations of glutamatergic inputs
express either α7 or α4β2∗ nAChRs while DA terminals projecting from the
VTA contain α4β2∗ nAChRs. Cholinergic inputs into the PFC arise from the
nucleus basalis of Meynert (nBM). (B) In the NAc, nAChRs (α4β2∗ , α6β2∗ ,
and α6α4β2∗ ) expressed on DAergic terminals from the VTA mediate DA
release based on the neuronal activity firing rate. A small population of
tonically active cholinergic interneurons (∼2%) is synchronized with DA cell
firing. Glutamatergic inputs from the PFC endow α7 nAChRs. (C) The VTA
receives cholinergic innervation from the pedunculopontine (PPn) and
laterodorsal tegmental nuclei (LDTn). In addition to the nAChRs localized on
DA cell bodies, DAergic cell firing is modulated by α4β2∗ (and possibly α7)
nAChRs expressed on GABAergic interneurons and excitatory glutamatergic
afferents from the PFC and the PPn.
2000); however, β2∗-containing receptors rapidly desensitize.
Simultaneously, nicotine acts on α4β2∗ nAChRs located on
GABAergic neurons to induce a transient inhibition of DA activ-
ity. These nicotinic receptors will also subsequently desensitize
in the presence of nicotine with a net result being a reduction
in the inhibitory control of GABA on dopaminergic transmis-
sion (Mansvelder and McGehee, 2002). On the same time scale,
nicotine binds to α7 nAChRs present on glutamatergic termi-
nals in the VTA, whose activation increases glutamate release
onto NMDA-type glutamate receptors located on dopaminergic
cell bodies and increases the frequency of spontaneous excitatory
postsynaptic currents (sEPSCs) (Mansvelder andMcGehee, 2000;
Schilstrom et al., 2000; Marchi et al., 2002; Pidoplichko et al.,
2004). Hence, the cumulative result of nicotine acting on nAChRs
in the VTA is enhanced excitatory input onto DA neurons which
triggers reward-related high frequency burst firing resulting in
increased accumbalDA outflow (Corrigall et al., 1994; Nisell et al.,
1994; Schilstrom et al., 2000; Pidoplichko et al., 2004).
Several labs have investigated the specific subunit composi-
tions of the nAChRs that may be critical in the development
of nicotine dependence using cell-based heterologous expression
systems, transgenic mouse lines, and pharmacological manipu-
lations using nAChR ligands in animal behavior models (Tapper
et al., 2004; Steensland et al., 2007; Chatterjee and Bartlett, 2010;
Cahir et al., 2011). The α4β2∗ and α6β2∗ nAChR subtypes play an
essential role in mediating the rewarding effects of nicotine (Dani
and De Biasi, 2001; Nashmi et al., 2007), demonstrated by a lack
of nicotine-elicited DA release in β2 and α4 knockout mice and
a decrease in nicotine self-administration by mice lacking the α4,
α6, or β2 subunits compared to wild-types (Picciotto et al., 1998;
Marubio et al., 2003; Pons et al., 2008). By contrast, the role α7
nAChRs play in the reinforcing properties of nicotine is less clear.
Deletion of the α7 did not affect nicotine conditioned place pref-
erence (Walters et al., 2006) or self-administration (Pons et al.,
2008); however, high doses of the α7 nAChR antagonist methylly-
caconitine attenuated nicotine self-administration (Markou and
Paterson, 2001) and reduced the rewarding effects of nicotine
when infused directly into the VTA (Laviolette and van der Kooy,
2003).
The effects of ethanol in the VTA are more complex than the
effects of nicotine. Ethanol, unlike nicotine, is not a direct ago-
nist at nAChRs (Cardoso et al., 1999; Zuo et al., 2002) but can
modulate DA release by influencing the function of nAChRs in
both the VTA and NAc (Ericson et al., 1998, 2003; Larsson et al.,
2005). While local perfusion of ethanol into the VTA does not
increase DA release in the accumbens, infusion of ethanol into
the accumbens does elevate extracellular DA to a similar degree
as systemic administration (Ericson et al., 2003; Tuomainen et al.,
2003). However, ethanol infused into both regions simultane-
ously resulted in higher DA levels than when injected into the
NAc alone (Lof et al., 2007). Furthermore, perfusion of mecamy-
lamine (MEC, non-selective nAChR antagonist) into the VTA,
but not into the NAc, blocks DA release stimulated by systemic
administration of ethanol. It has been postulated that ethanol’s
actions in the NAc may facilitate the release of endogenous ACh
in the VTA, leading to activation of nAChRs and consequently
elevating accumbal DA release (Larsson et al., 2005). In sup-
port, voluntary ethanol intake in rats has been shown to cause
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FIGURE 3 | Schematic representation of nAChR subtypes and
circuit function in the hippocampus and amygdala. (A) In the
hippocampus, α7 and α4β2∗ nAChRs are abundantly expressed on pyramidal
cells and inhibitory interneurons. GABAergic interneurons have pre-synaptic
α7 nAChRs and somato-dendritic expression of α7 and α4β2∗ nAChRs.
Glutamatergic afferents have predominately pre-synaptic α7 nAChRs and only
low levels of α3β4∗ . (B) In the amygdala, cholinergic inputs from the
basal forebrain synapse in proximity to pre-synaptic nAChRs that
modulate both excitato y and inhibitory synaptic transmission.
Glutamatergic afferents and pyramidal neurons endow α7 nAChRs
and GABAergic interneurons express multiple nAChRs (α7, α4β2∗ , and
α3β4∗ ).
amygdala, and PFC (Kelley, 2004). Therefore, alterations in
structure or function in the hippocampus may be translated
by other brain regions that drive mal daptive behaviors associ-
ated with addiction. Most studies investigating the involvement
of nAChRs in synaptic plasticity have been conducted in the
hippocampus.
The α7 and α4β2∗ nAChRs (see Figure 3) are abundantly
expressed on GABAergic interneurons and pyramidal cells within
the hippocampus and are capable of modulating intracellu-
lar signaling molecules and downstream effectors that gov-
ern plasticity (Jones and Yakel, 1997; Vizi and Lendvai, 1999).
GABAergic interneuron populations express α7 nAChRs on
pre-synaptic terminals, whereas somato-dendritic compartments
endow both α7 and α4β2∗ nicotinic receptors (Radcliffe et al.,
1999; Alkondon and Albuquerque, 2001). Furthermore, mod-
ulation of glutamate synaptic transmission to pyramidal neu-
rons in the CA1 region is attributed to predominately α7
nAChRs but also to a minimal number of α3β4∗ nAChRs
(Gray et al., 1996; Ji et al., 2001; Alkondon and Albuquerque,
2002).
nAChR-mediated synaptic plasticity. Nicotinic receptors exert
a temporally- and spatially-dependent bidirectional control over
synaptic plasticity, both in vitro and in vivo (Table 2). For exam-
ple, in the CA1 region of hippocampal slices ACh and nico-
tine can act on post-synaptic receptors of pyramidal neurons
to increase intracellular Ca2+ which facilitates the conversion of
short-term potentiation to LTP by reducing the threshold needed
for induction (Fujii et al., 1999; Ji and Dani, 2000; Nakauchi
et al., 2007) or by attenuating the inhibitory input of interneu-
rons to pyramidal cells (Ji and Dani, 2000; Yamazaki et al.,
2005); these effects are mediated by both the activation of non-α7
nAChRs and the inactivation of α7 nAChRs (Fujii et al., 2000a).
Furthermore, blunting the evoked release of inhibitory GABA
onto pyramidal cells to facilitate nicotine-induced LTP induction
was shown to rely on desensitization of non-α7 nAChRs (Fujii
et al., 2000b; Yamazaki et al., 2005; Nakauchi et al., 2007).
Additionally, activation of nAChRs on hippocampal interneu-
rons can induce LTP or LTD depending on the exact timing
of agonist application in respect to the pre-synaptic stimula-
tion (Ji et al., 2001; Ge and Dani, 2005). Furthermore, acti-
vation of α7 nAChRs on pre-synaptic glutamatergic terminals
can increase the frequency of miniature EPSCs and enhance
glutamate release onto pyramidal neurons offering yet another
mechanism for the modulation of plasticity (Gray et al., 1996;
Radcliffe and Dani, 1998). In the CA3 region of hippocam-
pal slices, bath application of nicotine can drive the pyrami-
dal cells above threshold in the absence of an action poten-
tial by activating pre-synaptic nAChRs located on glutamater-
gic terminals. Activation of these receptors enhances miniature
EPSCs and glutamate release through mobilization of intra-
cellular calcium stores by CICR (Sharma and Vijayaraghavan,
2003).
Within the dentate gyrus, induction of LTP by nicotine
required activation of mGLuR5 and L-type Ca2+ channels, as
well as Ca2+ release from ryanodine-sensitive stores and was α7
nAChR-dependent (Welsby et al., 2006, 2009). in vivo studies
in mice showed nicotine or epibatidine, an α4β2 nAChR ago-
nist, dose-dependently induced synaptic plasticity in the dentate
gyrus and importantly, required intact midbrain DA signaling
(Matsuyama et al., 2000; Matsuyama and Matsumoto, 2003; Tang
and Dani, 2009). In the developing brain, long-lasting changes
in synaptic transmission were observed following a single expo-
sure to nicotine in the hippocampus. nAChR signaling facilitated
the conversion of pre-synaptic silent synapses into functional
ones and was shown to be dependent on α7 nAChRs most likely
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FIGURE 3 | Schematic representation of nAChR subtypes and
circu t f nction n the hippocampus and amygdala. (A) In the
hippocampus, α7 and α4β2∗ nAChRs are abundantly expr sed on pyramidal
cells and inhibitory inter eurons. GABAergic inter eurons have pr -synaptic
α7 nAChRs and somato-dendritic expr ssion of α7 and α4β2∗ nAChRs.
Glutamatergic afferents have pr dominately pre-synaptic α7 nAChRs and o ly
low eve s of α3β4∗ . (B) In the amygdala, cholinergic inputs from the
basal forebrain sy apse in proximity to pre-synaptic nAChRs that
modulate both excitatory nd inhibitory synaptic transmission.
Glutamatergic afferents and pyramidal neurons e dow α7 nAChRs
and GABAergic inter eurons expr ss multiple nAChRs (α7, α4β2∗ , and
α3β4∗ ).
amygdala, nd PFC (Kelley, 2004). Therefore, alterations in
struct re or function i the ippocampus may be translated
by other b ain regions tha drive maladaptive b haviors associ-
ated with addiction. Most studies nvestigating the invol em nt
of nAChRs in synaptic plastici y have b en conducted in the
hippocampus.
The α7 and α4β2∗ nAChRs (see Figure 3) are abunda tly
expressed on GAB ergic intern urons and pyramidal ce ls within
the ippocampus and are capable of modulating intracellu-
lar signali g molecules and downstream effectors tha gov-
ern plastici y (Jones and Yakel, 1997; Vizi and Lendvai, 1999).
GAB ergic ntern uron populations express α7 nAChRs on
pre-synaptic terminals, whereas somato-den ritic compartments
endow both α7 and α4β2∗ nicotinic receptors (Radcliffe et al.,
1999; Alkondon a d Albuquerque, 2001). Furthermore, mod-
ulation f glutam te synaptic ransmi sion to pyramidal neu-
rons in the CA1 region is attributed to predominately α7
nAChRs but also t a minimal number of α3β4∗ nAChRs
(Gray et al., 1996; Ji et al., 2001; Alkondon a d Albuquerque,
200 ).
nAChR-mediated synaptic plastici y. Nicotinic receptors exert
a temporally- and spatially-depende t bidirectional control over
synaptic plastici y, both in vitro and in vivo (Table 2). For exam-
ple, in the CA1 region of hippocampal slices ACh and ico-
tine can ct on post-synaptic receptors of pyramidal neurons
to increas intracellular Ca2+ whic facilitates he conversion f
short-term poten iation to LTP by reducing the t reshold need d
for induction (Fujii et al., 1999; Ji and Dani, 2000; Nakauchi
et al., 2007) or by attenuating the inh bitory input of intern u-
rons to pyramidal cells (Ji and Dani, 2000; Yam zaki et al.,
2005); these ffects are m diated by both the activa ion f non-α7
nAChRs and the inactiva ion f α7 nAChRs (Fujii et al., 2000a).
Furthermore, blunting the evoked releas of inh bitory GAB
ont pyramidal ce ls to facilitate nicotine-induced LTP induction
was show to rely on desen itiza o f non-α7 nAChRs (F jii
et al., 2000b; Yam zaki et al., 2005; Nakauchi et al., 2007).
Additionally, activa ion f nAChRs on hippocampal intern u-
rons can i duce LTP or LTD dependi g on the exact timing
of agonist applicat on i resp ct to he pre-synaptic stimula-
tion (Ji et al., 2001; Ge and Dani, 2005). Furthermore, acti-
vation f α7 nAChRs on pre-synaptic glutam tergic terminals
can i creas the frequ ncy of miniature EPSCs and enha ce
glutam te releas ont pyramidal neurons offering yet another
mechanism for the modulation f plastici y (Gray et al., 1996;
Radcliffe and Dani, 1998). In the CA3 region of hippocam-
pal slices, bath applicat on f nicotine can drive the pyrami-
dal cells above threshold in the absenc of an ction poten-
tial by activa ing pre-synaptic nAChRs located on glutam ter-
gic terminals. Activa ion f these receptors enha ces miniature
EPSCs and glutam te r leas through mobilizat on of intra-
cellular calcium stores by CICR (Sharma and Vijayaragh van,
2003).
Within the dentate gyrus, induction of LTP by nicotine
required activa ion f mGLuR5 and L-type Ca2+ channels, a
well as Ca2+ releas from ryanodine-sen itive stores and was α7
nAChR-depend t (Welsby et al., 2006, 2009). in vivo studies
in mice showed nicotine or epibatidine, an α4β2 nAChR ago-
nist, dose-d pend tly induced synaptic plastici y n the d ntate
gyrus and importan ly, required intact midbrain DA signali g
(Matsuyam et al., 2000; Matsuyam and Matsumoto, 2003; Tang
and Dani, 2009). In the d veloping brain, long-lasting changes
in synaptic ransmi sion were observ d following a single expo-
sure to nicotine i the ippocampus. nAChR signali g facilitated
the conversion f pre-synaptic silent synapses into functional
ones and was shown to be d pende t on α7 nAChRs most like y
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FIGURE 2 | Schematic representation of nAChR subtypes and circuit
function in the mesolimbic dopaminergic system. (A) Pyramidal cells in
layer V of the PFC lack nAChRs but their activity is modulated by excitatory
and inhibitory neurons that do express them. There are two types of
GABAergic interneurons, fast spiking and non-fast spiking, with only the latter
bearing nAChRs (α7 and α4β2∗ ). Distinct populations of glutamatergic inputs
express either α7 or α4β2∗ nAChRs while DA terminals projecting from the
VTA contain α4β2∗ nAChRs. Cholinergic inputs into the PFC arise from the
nucleus basalis of Meynert (nBM). (B) In the NAc, nAChRs (α4β2∗ , α6β2∗ ,
and α6α4β2∗ ) expressed on DAergic terminals from the VTA mediate DA
release based on the neuronal activity firing rate. A small population of
to ically active cholinergic interneurons (∼2%) is synchronized with DA cell
firing. Glutamatergic inputs from th PFC endow α7 nAChRs. (C) The VTA
receives cholinergic innervation from the pedunculopontine (PPn) and
laterodorsal tegmental nuclei (LDTn). In addition to the nAChRs localized on
DA cell bodies, DAergic cell firing is modulated by α4β2∗ (and possibly α7)
nAChRs expressed on GABAergic interneurons and excitatory glutamatergic
afferents from the PFC and th PPn.
2000); however, β2∗-containing receptors rapidly desensitize.
Simultaneously, nicotine acts on α4β2∗ nAChRs located on
GABAergic neurons to induce a transient inhibition of DA activ-
ity. These nicotinic receptors will also subsequently desensitize
in the presence of nicotine with a net result being a reduction
in the inhibitory control of GABA on dopaminergic transmis-
sion (Mansvelder and McGehee, 2002). On the same time scale,
nicotine binds to α7 nAChRs present on glutamatergic termi-
nals in the VTA, whose activation increases glutamate release
onto NMDA-type glutamate receptors located on dopaminergic
cell bodies and increases the frequency of spontaneous excitatory
postsynaptic currents (sEPSCs) (Mansvelder andMcGehee, 2000;
Schilstrom et al., 2000; Marchi et al., 2002; Pidoplichko et al.,
2004). Hence, the cumulative result of nicotine acting on nAChRs
in the VTA is enhanced excitatory in t onto DA neurons which
triggers reward-related high frequency burst firing resulting n
increased accumbalDA outflow (Corrigall et al., 1994; Nisell et al.,
1994; Schilstrom et al., 2000; Pidoplichko et al., 2004).
Several labs have investigated the specific subunit composi-
tions of the nAChRs that may be critical in the development
of nicotine dependence using cell-based heterologous expression
systems, transgenic mouse li es, and pharm cological manipu-
lations using nAChR ligands in animal beh vior models (Tapper
et al., 2004; Steensland et al., 2007; Chatterjee and Bartlett, 2010;
Cahir et al., 2011). The α4β2∗ and α6β2∗ nAChR subtypes play an
essential role in mediating the rewarding effects of nicotine (Dani
and De Biasi, 2001; Nashmi et al., 2007), demonstrated by a lack
of nicotine-elicited DA release in β2 and α4 knockout mice and
a decrease in nicotine self-administration by mice lacking the α4,
α6, or β2 subunits compared to wild-types (Picciotto et al., 1998;
Marubio et al., 2003; Pons et al., 2008). By contrast, the role α7
nAChRs play in the reinforcing properties of nicotine is less clear.
Deletion of the α7 did not a fect nicotin con itioned place pref-
erence (Walters et al., 2006) or self-administration (Pons et al.,
2008); however, high doses of the α7 AChR antag ist methylly-
caconitine attenuated nicotine self-administration (Markou and
Paterson, 2001) and reduced the rewarding effects of nicotine
when infused directly into the VTA (Laviolette and van der Kooy,
2003).
The effects of ethanol in the VTA are more complex than the
effects of nicotine. Ethanol, unlike nicotine, is not a direct ago-
nist at nAChRs (Cardoso et al., 1999; Zuo et al., 2002) but can
modulate DA release by influencing the function of nAChRs in
both the VTA and NAc (Ericson t al., 1998, 2003; Larsso et al.,
2005). While loca perfusi of ethanol into the VTA do s not
increase DA release in the accumbens, infusion of ethanol into
the accumbens does elevate extracellular DA to a similar degree
as systemic administration (Ericson et al., 2003; Tuomainen et al.,
2003). However, ethanol infused into both regions simultane-
ously resulted in higher DA levels than when injected into the
NAc alone (Lof et al., 2007). Furthermore, perfusi n f me my-
lamine (MEC, n n-selective nAC R antagon st) into the VTA,
but not into the NAc, blocks DA release stimulated by systemic
administration of ethanol. It has been postulated that ethanol’s
actions in the NAc may facilitate the release of endogenous ACh
in the VTA, leading to activation of nAChRs and consequently
elevating accumbal DA release (Larsson et al., 2005). In sup-
port, voluntary ethanol int ke in rats has been shown to cause
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Figure 1.2: Sche atic represe tatio of nAChR subtypes f r ar as important for
cigarette dependence. Caption on following page.
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1.4 Nicotine’s effect − greater than just dopamine release
The presence of nicotine in the brain and body does more than just release DA.
The influx of nicotine with each cigarette causes an increase in signaling for multiple
other neurotransmitter systems including acetylcholine, glutamate, γ−aminobutyric
acid (GABA), serotonin, norepinephrine, and beta−endorphin (Figure 1.3) [49; 50].
The upregulation of all of these other neurotransmitter systems, along with that of DA
combine to make the rewarding and reinforcing properties of cigarette addiction. Fur-
ther, it is this upregulation and alteration in receptor expression across neurotransmit-
ter systems that creates the physiological and psychological symptoms of withdrawal.
These symptoms include agitation, irritability, anxiety, depression, decreased cognition,
headaches, hunger, and cigarette craving.
Figure 1.2. Schematic representation of nAChR subtypes for areas important for
cigarette dependence A. Pyramidal cell activity in layer V of the PFC is modulated
by excitatory and inhibitory neurons expressing nAChRs. Non−fast spiking GABAer-
gic interneurons bear nAChRs (α7 and α4β2). Distinct populations of glutamatergic
inputs express either α7 or α4β2 nAChRs while DA terminals projecting from the
VTA contain α4β2 nAChRs. Cholinergic inputs into the PFC arise from the nucleus
basalis of Meynert (nBM). B. In the NAc, nAChRs (α4β2, α6β2, and α6α4β2) ex-
pressed on DAergic terminals from the VTA mediate DA release based on the neuronal
activity firing rate. A small population of tonically active cholinergic interneurons
(2%) is synchronized with DA cell firing. Glutamatergic inputs from the PFC endow
α7 nAChRs. C. The VTA receives cholinergic innervation from the pedunculopon-
tine (PPn) and laterodorsal tegmental nuclei (LDTn). In addition to the nAChRs
localized on DA cell bodies, DAergic cell firing is modulated by α4β2 (and possibly
α7) nAChRs expressed on GABAergic interneurons and excitatory glutamatergic af-
ferents from the PFC and the PPn. D. In the hippocampus, α7 and α4β2 nAChRs
are abundantly expressed on pyramidal cells and inhibitory interneurons. GABAer-
gic interneurons have pre−synaptic α7 nAChRs and somato−dendritic expression of
α7 and α4β2 nAChRs. Glutamatergic afferents have predominately pre−synaptic α7
nAChRs and only low levels of α3β4. E. In the amygdala, cholinergic inputs from
the basal forebrain synapse in proximity to pre−synaptic nAChRs that modulate both
excitatory and inhibitory synaptic transmission. Glutamatergic afferents and pyrami-
dal neurons endow α7 nAChRs and GABAergic interneurons express multiple nAChRs
(α7, α4β2, and α3β4). Adapted and printed with permission from [33].
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inant in the human brain and is believed to be the main
receptor mediating nicotine dependence. In mice, knocking
out the !2 subunit gene eliminates the behavioral effects of
nicotine, including self-administration.23 Reinserting the !2
subunit gene into the ventral tegmental area of a !2 knock-
out mouse restores behavioral responses to nicotine.24  The
"4 subunit appears to be an important determinant of sen-
sitivity to nicotine. In mice, a single nucleotide point mu-
tation in the pore-forming region results in a receptor that is
hypersensitive  to  the  effects  of  nicotine.25  This  mutation
made mice much more sensitive to nicotine-induced reward
behaviors, as well as to effects on tolerance and sensitiza-
tion. The "3!4 and possibly the "7 homomeric receptor
subtypes are believed to mediate the cardiovascular effects
of nicotine.26 The "7 subtype is also thought to be involved
in rapid synaptic transmission and may play a role in learn-
ing27  and sensory gating.28
Biology of Nicotine Reinforcement
Brain imaging studies demonstrate that nicotine acutely
increases activity in the prefrontal cortex, thalamus, and
visual system, consistent with activation of corticobasal
ganglia-thalamic  brain  circuits.29  Stimulation  of  central
nAChRs by nicotine results in the release of a variety of
neurotransmitters in the brain, most importantly dopamine.
Nicotine causes the release of dopamine in the mesolimbic
area, the corpus striatum, and the frontal cortex. Of partic-
ular importance are the dopaminergic neurons in the ventral
tegmental area of the midbrain and the release of dopamine
in the shell of the nucleus accumbens, as this pathway
appears  to  be  critical  in  drug-induced  reward.22,30  Other
neurotransmitters, including norepinephrine, acetylcholine,
serotonin, #-aminobutyric acid (GABA), glutamate, and
endorphins, are released as well, mediating various behav-
iors of nicotine (Figure 1).5
It is believed that most of the release of neurotransmitters
occurs via modulation by presynaptic nAChRs, although
direct release of neurotransmitters also occurs.31 Dopamine
release is facilitated by nicotine-mediated augmentation of
glutamate release and, with long-term treatment, by inhibi-
tion of GABA release. In addition to direct and indirect
stimulation of neurotransmitter release, chronic cigarette
smoking (but not acute nicotine administration) reduces
brain monoamine oxidase A and B activity, which would be
expected to increase monoaminergic neurotransmitter levels
such as dopamine and norepinephrine in synapses, thus
augmenting the effects of nicotine and contributing to ad-
diction.29
Dopamine release signals a pleasurable experience and is
critical to the reinforcing effects of nicotine and other drugs
of abuse.30 Chemically or anatomically lesioning dopamine
neurons in the brain prevents nicotine self-administration in
rats.32 When intracranial self-stimulation is used as a model
for brain reward in rats, nicotine acutely lowers the thresh-
old  for  self-stimulation.33  Thus,  through  its  effects  on do-
pamine release, acute nicotine administration increases
brain reward function. Likewise, nicotine withdrawal is
associated with significant increases in intracranial self-
stimulation reward threshold, consistent with deficient do-
pamine release and reduced reward.34  This is similar to the
effects of withdrawal from other drugs of dependence. The
decrease in brain reward function experienced during nico-
tine withdrawal is an essential component of nicotine ad-
diction and a key barrier to abstinence.
With repeated exposure to nicotine, there is neuroadap-
tation  to  some,  but  not  all,  of  the  effects  of  nicotine.35
Concurrent with this neuroadaptation is an increase of
nAChRs in the brain. This increase is believed to represent
upregulation in response to nicotine-mediated desensitiza-
tion of receptors. This desensitization may play a role in
nicotine tolerance and dependence. It has been suggested
that craving and withdrawal symptoms begin in chronic
smokers when previously desensitized "4!2 nAChRs be-
come unoccupied and recover to a responsive state during
periods  of  abstinence,  such  as  during  nighttime  sleep.36
Thus, nicotine binding and desensitization of these recep-
tors during smoking may alleviate craving and withdrawal.
This is supported by clinical evidence that cigarette smok-
ing in amounts used by typical daily smokers maintains
near-complete saturation—and, thus, desensitization—of
Figure 1 Nicotine receptor activation promotes the release of neurotransmitters, which may then mediate various effects of nicotine use.
GABA ! #-aminobutyric acid. (Adapted with permission from Prim Care.5)
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Figure 1.3: Nicotine receptor activation promotes the release of neurotransmitters,
which then mediate various effects of nicotine use. GABA = γ−aminobutyric acid.
Printed with permission from c© [49]
1.5 There is more to cigarettes than nicotine
M st f what we know about the eurobiology of cigarette addiction has come from
wo k in animal models of icotine addiction, as nicotine is id ntified as the prima y
addictive ingredient in cigarettes [49]. However, recently the cigarette dependence
research community has stepped back to acknowledge the existence of the 7000 other
chemicals in cigarette smoke and that studying just the effect of nicotine on the brain
and behavior is not the same as studying the effects of cigarettes on the brain an
behavior. To study the effect cig rette smoke has on neurobiol gy, investigators are
turning to the use of actual cigarett smoke in experiments or by creating cigarette
smoke extract via the condensation of cigarette smoke into a liquid. This new direction
of study is promising, and will help to paint a more realistic and complete understanding
of cigarette dependen e, and how cig rettes affect brain biology, structure, and functi n.
1.6 Smoking and Neuroimaging
The study of cigarette dependence using human neuroimaging, however, affords us
with the abilit to study cig rette addiction in its na ural sta e, ex mining the ad-
diction to nicotine as well as all other components of cigarette smoke. However, due
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to the large comorbidity of cigarette smoking with other human disorders (alcohol use
disorders, schizophrenia, depression, etc), imaging literature looking singularly at the
effects of cigarette dependence in otherwise healthy individuals is scarce. Of the exist-
ing literature in just cigarette smokers, most investigations utilize functional imaging
to understand the anatomical underpinnings of craving, attention to smoking cues,
memory, cognition, and impulsivity. Studies looking at structural abnormalities in the
brains of cigarette smokers using anatomical magnetic resonance imaging (sMRI) or
diffusion tensor imaging (DTI) are few, and have been largely limited by the analytical
methods employed. Thankfully, due to advancements in image acquisition and analysis
techniques, the field is at an exciting time to study the structural abnormalities in the
brains of cigarette smokers.
1.7 Measurements of smoking consumption and addiction severity
While most studies are cross sectional, investigators are interested to know if struc-
tural or functional differences in the brains of cigarette smokers correlate with total
cigarette exposure. There are two main self−report measures used to capture the
amount of cigarette exposure consisting of: a reported average number of cigarettes/day
and pack years, with pack years generally computed from cigarettes/day and years
smoking. In addition to self−report, there are biological measures that can be used to
quantify the level of cigarette consumption, including exhaled carbon monoxide (CO)
concentration, and urine or saliva levels of cotinine, a metabolite of nicotine. Continine
measurements are the most sensitive way to determine the level of recent smoking, how-
ever, no truly quantitative rapid measures of continine are currently available, making
it difficult to assess smoking status in real time. Exhaled CO provides an easy alter-
native for measuring smoking within the past 24 hours, with CO having a half life of
3−6 hours [51].
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While clinical diagnosis of nicotine dependence is made using a structured interview
and DSM criteria, in the lab it is useful to have shorter questionnaires with continuous
scales in order to capture a range of addiction severity. In almost all cigarette depen-
dence studies investigators use the Fagerstrom Test for Nicotine Dependence (FTND)
[52]. While several other similar measures exist, even some that have been shown to
perform superiorly to the FTND, the field continues to use the FTND. This may be
in part due to tradition, and in part due to the fact that at this point some 30 years
of research has been performed using this test where it has been found to correlate
with many important aspects of cigarette addiction. One of the available tests that
has been shown to perform better than the FTND on measures of construct and pre-
dictive validity is the Cigarette Dependence Scale (CDS) [53; 54]. With the exception
of tolerance, the CDS covers the main criteria for ICD−10 and DSM−IV definitions of
dependence: withdrawal symptoms, compulsion, loss of control, time allocation, neglect
of other activities, and persistence despite harm [55]. We believe the CDS provides a
more accurate measurement of cigarette addiction severity and thus it is the measure
that we use in this study.
1.8 Measuring behavioral impulsivity − the delay discounting task
One feature of addiction that may play into the cycle of quit attempt and relapse, is
that people with addictive disorders, including cigarette dependence, characteristically
display impulsive choice behavior [56; 57; 58]. In the lab, one way to measure this
impulsive choice behavior is through the use of a delay discounting task. Generically
this task is composed of multiple trials where the participant is presented with a choice
between two options, a choice of a small reward available immediately or a larger reward
available at various delays. Across multiple forms of addiction, those with addiction
disorders are far more likely to choose the smaller sooner reward than normal controls.
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This impulsive choice behavior holds true for those dependent on cigarettes as well
[56; 57; 58]. While this task originated on paper, it has since been modified to work on
a computer, as well as for use in a MRI scanner to allow for functional imaging during
the task [59].
1.9 The circuitry of episodic memory
Episodic Memory (EM) is the ability to retrieve event−specific information from
your life, which is accompanied by a feeling of re−experiencing the event at retrieval
[60; 61]. In the lab, EM has been subdivided into distinct event−specific information
(e.g. what words were on a list you memorized, what was their location, and did you
see a certain word before this other word?) and personally significant (i.e. autobio-
graphical) EM (e.g. what did you wear to your senior prom?) [62]. Outside of the
lab, however, recalling episodes from ones past involves specifically autobiographical
memory with the associated details, emotions, and rich context [63; 64; 65; 66; 67].
This capacity to re−experience memories from our own past relies upon a rich net-
work of brain regions known as the episodic memory network. The episodic memory
circuit includes nodes in the temporal lobe (the hippocampus, parahippocampal cor-
tex (PHC), amygdala, rhinal cortex, temporopolar cortex, lateral temporal cortex), the
frontal lobe (medial prefrontal cortex (mPFC), ventrolateral prefrontal cortex (vlPFC),
dorsolateral PFC (dlPFC), frontopolar cortex, orbitofrontal cortex (OFC), anterior cin-
gulate cortex (ACC)), the parietal lobe (retrosplenial/posterior cingulate cortex (PCC),
inferior parietal lobe, temporoparietal junction), the insula, the occipital cortex, and
several subcortical structures (caudate, anterior thalamus, mammillary bodies, cerebel-
lum) [68; 67; 63; 66; 61; 69; 70; 65; 71; 72; 73; 66; 64; 74; 75]. White matter tracts
implicated in episodic memory connect these nodes, including the uncinate fasciculus,
cingulum bundle, and fornix [73; 76; 77]. Critically, this circuitry is the same as that
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needed for episodic prospection [78; 68; 75; 71; 79; 78].
1.10 Imagining future events reduces delay discounting − Implications for
cigarette dependence
Two recent studies have shown that episodic prospection (imagining future events)
reduces discounting of delayed rewards in healthy control participants via enhanced
connectivity between the frontal lobe and mediotemporal regions mediating episodic
prospection [80; 81]. As noted above, cigarette smokers have a heightened tendency
to discount delayed rewards; however the neural bases of this tendency are not fully
understood. Thus, a possible neural mechanism underlying enhanced delay discounting
in cigarette smokers is impaired connectivity between frontal regions and the circuitry
engaged during episodic prospection. Moreover, behavioral studies have demonstrated
that those with cigarette dependence commonly exhibit impaired episodic memory, sug-
gesting possible specific structural deficits in the episodic circuitry [82; 83]. Together,
these observations have led us to the following hypothesis:
Hypothesis: Individuals with cigarette dependence show variations in the
structural properties of the episodic memory circuitry that correlate with
cigarette addiction severity, particularly its connections to frontal elements
of decision−making circuits.
We investigated this hypothesis using a novel framework for diffusion tensor imaging
(DTI) tractography analysis (Chapter 3), and an established framework for the analysis
of cortical and subcortical volumes, and cortical thickness, FreeSurfer (Chapter 4) [84;
85; 86; 87; 88; 89; 90; 91; 92; 93; 94; 95; 96; 97].
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AD = axial diffusion = λ1 RD = radial diffusion = (λ2 + λ3)/2 
λ1 
λ2  
λ3 
MD = mean (overall) diffusion 
=      = (λ1 + λ2 + λ3)/3 
FA = fractional anisotropy (tensor shape) 
Figure 1.4: Measurements of diffusion used in DTI analysis. Diffusion parameters for
DTI analysis are calculated from the first three primary eigenvalues (λ1, λ2, λ3). The
top image shows how the three primary eigenvalues would describe diffusion for a single
water molecule moving down a neuronal axon. The primary direction of diffusion is
defined as the first eigenvalue (λ1). A combination of the second and third eigenvalues
describe water diffusion orthogonal to the axon (λ2, λ3). Together, the first three
eigenvalues of diffusion are used to compute the fractional anisotropy (FA), which
describes the shape of the diffusion tensor (bottom center image). Adapted and printed
with permission from: http: // www. clker. com/ clipart-9828. html
1.11 Prior neuroimaging findings in smokers within the circuitry impli-
cated in episodic prospection and decision−making
1.11.1 Diffusion Tensor Imaging (DTI)
Diffusion tensor imaging (DTI) is the study of the movement of water molecules,
with the assumption that the diffusion of water is restricted by the macro and mi-
crostructure of its environment. Thus water molecules located in the lateral ventricle
with a large space for diffusion, will likely diffuse by Brownian motion in an isotropic
(spherical) manner. However, water molecules located within a fiber bundle or neuronal
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axon will have their diffusion limited by the dense macrostructure of many surround-
ing axons in a white matter tract, as well as the microstructure of myelin surrounding
axons, and organelles and microtubules within individual axons making their diffusion
described as more anisotropic (linear) in nature. Under these assumptions we can then
measure to what degree water diffusion is linear, or the fractional anisotropy (FA), in re-
gions of interest in the brain. Composing the measurement of FA are the measurements
of axial, radial, and mean diffusivity. Axial diffusivity (AD) is the primary direction of
water diffusion, or the first eigenvalue, and is also described as the diffusion of water
that is parallel to the fiber bundle or axon. Radial diffusivity (RD) is the average of
the second and third eigenvalues, which describe the magnitude of diffusion orthogonal
to the axon or fiber bundle. Mean diffusivity (MD), is then an average of the first three
eigenvalues, and describes the overall amount of diffusion. FA combines all three of
these other measurements to describe the overall shape of the diffusion tensor (Figure
1.4).
As FA and MD combine multiple measurements into one reading, they are generally
considered to be more stable measurements of diffusion and often are the only two
reported diffusion parameters in manuscripts. Traditionally FA is taken to represent
a measurement of microstructural integrity and/or fiber bundle organization, and is
the diffusion parameter of primary interest. However, interpretation of FA is only
possible by referring to the diffusion parameters of axial, radial, and mean diffusivity.
Changes in radial diffusivity are often seen as alterations in myelin integrity, but can
also represent changes in fiber bundle organization. Decreases in axial diffusivity are
often interpreted as cell death that has lead to axon degeneration, but again can suggest
alterations in fiber bundle organization [98].
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+ Robust against imperfect registration 
-  Multiple tracts/tissues within one ROI 
+ Good for hypothesis generation 
- Requires PERFECT registration 
B 
+ Works well with imperfect registration  
-  Multiple tracts combined on skeleton 
-  Max FA is a less stable measurement 
C A 
Figure 1.5: Prior methods used for DTI analysis. A. Region of interest (ROI) analysis
displayed here with ROIs from the Susumu Mori atlas. DTI analysis performed with
large ROIs as displayed here often average the diffusion within the entire ROI for a
single measurement, combining readings from multiple white matter tracts into one
region, as well as combining together diffusion in white matter and grey matter. This
leads to results that are not localizable to a specific tract or a specific region on a tract.
Adapted and printed with permission from [99]. B. Whole brain voxel based analysis
used to find single voxels of significance. This method assumes perfect registration on
the voxel level between participants, which is often not possible. This method is a great
way to generate hypotheses for future studies using a more specific method of analysis.
unpublished figure from our lab. C. Tract based spatial statistics (TBSS) is a form
of voxel based analysis. For this method a white matter skeleton is constructed and
the max FA located perpendicularly to the skeleton is assigned to that location on the
skeleton. Like ROI analysis, this method also often combines information of multiple
white matter tracts into a single measurement. Thus findings are not truly localizable
to a single tract. Further, the use of max FA is not a very reliable measurement of
diffusion. A weighted average of diffusion in the environment is a better measure of
diffusion that protects against outliers and takes into account the neighborhood of
diffusion. TBSS does work better than whole brain voxel based analysis, as it does
not require absolutely perfect registration. Adapted and printed with permission from
[100].
18
Prior investigations of DTI in smoking
To date, little work has investigated the relationship between cigarette smoking and
white matter (WM) integrity of the brain using DTI. Of the studies that exist, most
utilize voxel wise analysis, TBSS (a form of voxel wise analysis), or large nonspecific
regions of interest (ROIs), and do not perform specific along the tract tractography
analysis (Figure 1.5) [101; 99; 100; 102]. Thus previously reported DTI findings in
smokers are not truly localizable to specific tracts or to exact locations along tracts
(Figure 1.5). When comparing smokers to nonsmokers using these DTI analysis tech-
niques, findings have been mixed. While most studies report smokers to have increased
FA in regions of the brain compared to nonsmokers [103; 104; 105; 106; 107], oth-
ers find smokers to have decreased FA [108; 109], or no difference in FA [110; 111].
Likewise there are varying conclusions as to how cigarette consumption and addiction
severity relate to WM integrity in smokers. Studies have found a negative correlations
[104; 110; 106; 107], positive correlations [103], or no correlation [105; 109] between
measures of addiction severity and FA.
There may be several reasons for these discrepancies in findings, one of which is the
use of nonspecific voxel wise or ROI−based analyses. With these analytical techniques,
single average measurements of diffusion parameters (FA, MD, RD, AD) are used to
represent entire fiber bundles, when the regions analyzed may consist of multiple WM
tracts, or may contain both white and grey matter. In order to better understand
how cigarette smoking addiction affects WM integrity, a more specific and localizable
technique needs to be applied.
To address this gap in the literature, we developed a DTI analysis framework (Chap-
ter 2) for along the tract investigation of diffusion in cigarette smokers and non−smokers
(Chapter 3).
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1.11.2 Structural MRI (sMRI)
Study of structural (anatomical) MRI images aids in determining differences in
brain region volumes between smokers and non−smokers. Two forms of methods avail-
able for this form of analysis are voxel based morphometry (VBM) and surface based
morphometry (FreeSurfer). VBM uses a previously segmented atlas to compute tissue
probability maps for each subject in order to segment the brain into white matter, grey
matter, and cerebrospinal fluid (CSF). VBM does this segmentation and the follow-
ing statistical tests on a voxel by voxel basis [112]. Results from VBM are typically
reported as either measurements of volume or density.
In addition to segmenting cortical and subcortical brain volumes like VBM, FreeSurfer
is also capable of computing cortical thickness and white matter surface area measure-
ments. The publicly available FreeSurfer1 software assesses bilateral regional cortical
and subcortical volumes, and regional cortical thickness [85; 86; 87; 88; 89; 90; 91;
92; 93; 94; 95; 96; 97]. Briefly, this processing includes T1 motion correction [93],
removal of non−brain tissue using a hybrid watershed/surface deformation procedure
[86], automated Talairach transformation, segmentation of the subcortical white matter
and deep gray matter volumetric structures [87; 94], intensity normalization Sled1998,
tessellation of the gray matter white matter boundary, automated topology correction
[89; 90], and surface deformation following intensity gradients to optimally place the
gray/white and gray/cerebrospinal fluid borders at the location where the greatest shift
in intensity defines the transition to the other tissue class [85; 91; 92]. Once the corti-
cal models are complete, a number of deformable procedures can be performed for in
further data processing and analysis including surface inflation [95], registration to a
1http://surfer.nmr.mgh.harvard.edu/
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spherical atlas which utilized individual cortical folding patterns to match cortical ge-
ometry across subjects [96], parcellation of the cerebral cortex into units based on gyral
and sulcal structure [97], and creation of a variety of surface based data including maps
of curvature and sulcal depth. This method uses both intensity and continuity infor-
mation from the entire three dimensional MR volume in segmentation and deformation
procedures to produce representations of cortical thickness, calculated as the closest
distance from the gray/white boundary to the gray/CSF boundary at each vertex on
the tessellated surface [92]. The maps are created using spatial intensity gradients
across tissue classes and are therefore not simply reliant on absolute signal intensity.
The maps produced are not restricted to the voxel resolution of the original data thus
are capable of detecting submillimeter differences between groups.
Prior investigations of sMRI in smoking
When compared to nonsmokers, previous studies using these VBM or FreeSurfer
found smokers to have decreased grey matter volume and density in the anterior cin-
gulate, prefrontal cortex (PFC), orbital frontal cortex (OFC), frontal cortex, parahip-
pocampal gyrus, temporal lobe, hippocampus, hippocampus subfields, thalamus, sub-
stantia nigra, insula, and total brain [113; 114; 110; 115; 116]. These decreases in
volume/density in smokers negatively correlated with pack years for the frontal lobe,
temporal lobe, left PFC, hippocampus, subiculum, and presubiculum [113; 110; 115].
Decreased cortical thickness was also found in the anterior cingulate cortex, insula, to-
tal brain reward system, total frontal cortex, and medial OFC, with the decrease in the
OFC cortical thickness correlating with cigarettes per day and pack years [117; 118].
While several studies have investigated cortical and subcortical volumes, cortical thick-
ness evaluation is new to the field and it is of great interest to specifically investigate
cortical thickness and volume for the brain regions implicated in episodic prospection
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and decision−making. Thus to add to existing literature, we utilized FreeSurfer to
investigate the cortical and subcortical volumes, and cortical thickness of brain regions
implicated in episodic memory and decision−making (Chapter 4).
Benefits of multi−modal analysis
Using both DTI and sMRI to analyze the same dataset of cigarette smokers and non-
smokers allows us to acquire information about the same story from different angles.
DTI affords us the knowledge of what is happening to water diffusion in the brain
and how these changes may be related to structural alterations in white matter tracts.
How diffusion parameters change provides clues as the biology occurring and what may
be causing the structural alterations in the WM. sMRI analysis provides information
on the brain grey matter. Again, whether it is cortical volume or thickness changing
provides information as to the biological process occurring in the tissues. If we had
fMRI data, this could further help to complete the picture of what biologically is going
on in cigarette smokers. It could help answer whether the structural alterations we see
in the WM and GM are correlated with functional changes or behavioral alterations.
Each imaging modality provides a different piece of the puzzle with information on
the potential biological process that compliments findings from other modalities. The
challenge is then taking all of the puzzle pieces and trying to figure out how they all
fit together to make the full picture of disease.
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CHAPTER 2
UNC−UTAH NA−MIC FRAMEWORK FOR DTI FIBER TRACT
ANALYSIS
1
2.1 Foreword
Dr. Styner’s lab is specialized in creating cutting edge, open source processing and
analysis tools for use in the investigation of diffusion tensor images (DTI), anatomical
magnetic resonance images (MRI), and MRI shape analysis. When I joined the lab in
the summer of 2011 many tools for the processing and analysis of DTI were available
in command line format, but were not accessible to investigators without a computer
science background. In order to make these tools usable by any researcher that collects
DTI data, graphical user interfaces (GUIs) and advanced visualization options had to
be created for the existing tools, and new programs were required to make the analysis
pipeline seamless. Computer science students and research staff in Dr. Styner’s lab
set to work coding these new tool interfaces and as they finished testing the tools
from a development standpoint, I then assisted in testing them from the viewpoint of
a nave user providing design feedback, option ideas to improve usability, and help in
1This chapter is modified from Audrey R Verde, Francois Budin, Jean−Baptiste Berger, Aditya
Gupta, Mahshid Farzinfar, Adrien Kaiser, Mihye Ahn, Hans J Johnson, Joy Matsui, Heather C Hazlett,
Anouja Sharma A, Casey Goodlett, Yundi Shi, Sylvian Gouttard, Clement Vachet, Joseph Piven,
Hongtu Zhu, Guido Gerig, Martin A. Styner, UNC−Utah NA−MIC Framework for DTI Fiber Tract
Analysis., Frontiers in Neuroinformatics, 2014 Jan 9; 7(51). All previously published material was
reprinted with permission from the publishers.
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troubleshooting bugs that became apparent in processing.
I helped with the development, testing, and debugging of our DTI analysis frame-
work tools for the first two years of my thesis work. While the Styner lab focuses
mostly on neonatal and infant neurodevelopment analysis, my project is the only one
to study a disease of adulthood. Thus, since our goal was to create a DTI analysis
framework that any investigator could use, regardless of participant group age range,
it was to our advantage for me to test our proven infant DTI analysis framework with
an adult dataset. Assuring the ability of our tools to be broadly applied in the field of
DTI analysis.
However, when it came time to share our framework with the DTI field it was
important for us to include a companion dataset as a reference. This would allow new
investigators to use our freely available tools to process their data, and to check each
of the intermediate steps of analysis to the images provided in the example dataset. In
order to provide such a dataset, it required me to process images from a study where
the data could be made freely accessible. Unfortunately, my smoking dataset could not
fill this role. Thus, we turned to a different study that the Styner lab is involved in,
the Infant Brain Imaging Study (IBIS). This is a large, multisite, longitudinal, clinical
study of infants and their sibling at high and low risk for autism. Since much of this
dataset has already been published on, the images could be uploaded for public access.
Thus, we went forward to use this infant dataset to illustrate the power and outputs of
our DTI analysis tools. The manuscript describing our framework through the use of
this data can be found in Chapter 2, and contains a set of links where all of our tools
are accessible for download free of charge. While we are motivated and committed to
keeping these tool websites updated with the most current version of programs and to
address bugs and/or feature requests, we are not obligated nor supported by the NIH
for tool maintenance.
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While Chapter 2 illustrates our DTI analysis framework through the use of a neona-
tal dataset, the programs in our framework were first developed with and tested on my
smoking dataset, proving these tools to be powerful analysis techniques for both infant
and adult DTI. The resulting analysis of the smoking dataset with our DTI analysis
framework is showcased in Chapter 3. Thus with this framework freely accessible at
http://www.nitrc.org/projects/namicdtifiber, researchers in any field, cigarette
smoking or otherwise, have the tools and an example dataset available to them to help
in the successful processing and analysis of their own DTI data.
2.2 Introduction
Since its invention in the 1980s diffusion weighted imaging has become increasingly
popular for the analysis of brain pathologies and development. It is now standard
practice for investigators to collect diffusion weighted images (DWI) concurrently with
other modalities of interest without any expertise on how to preprocess or analyze DWI.
To address this growing wealth of DWI data, we have created a coherent framework of
tools for the pre−processing and analysis of DWI and diffusion tensor images (DTI)
that is accessible for the non−technical user. It is the aim of this paper to describe our
DTI processing workflow and to provide example data processed with this framework
for increased workflow clarity.
Diffusion weighted images (DWI) capture the movement of water molecules. When
locally unconstrained, such water molecules move by Brownian motion in an isotropic
spherical fashion, for example as is the case within the brain lateral ventricles. However
when locally confined, the diffusion of water molecules is constrained by local bound-
aries, such as cell membranes. Within the human brain white matter, largely composed
of neuronal axons, the diffusion of water is more ellipsoid or anisotropic in shape due to
the confines of the internal microstructure and the myelin surrounding neuron axons.
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Characterizing the properties of diffusion can inform us about the integrity of white
matter micro−structure and provides insight on the mechanisms and progression of dis-
ease. To date DTI has been used in research to further the understanding of pathology
in many neurologic diseases including multiple sclerosis [119], Alzheimer’s [120], and
Parkinson’s [121], as well as normal neurodevelopment [122] and aging [123]. The most
common properties measured in DWI/DTI are axial (AD, λ ‖), radial (RD, λ ⊥), and
mean diffusivity (MD), as well as fractional anisotropy (FA). Axial diffusivity has been
shown to decrease in the case of cell death, while radial diffusivity will increase in the
case of myelin damage [98]. Alterations in fractional anisotropy reflect changes of AD,
RD, and MD and describe the overall pattern of diffusion.
Several analysis frameworks exist for the study of DWI/DTI data, typically falling
into one of 3 categories: region of interest (ROI) based analysis, voxel based analysis,
and quantitative tractography. ROI driven analysis can be performed by registering
individual subject DWI images either to their corresponding anatomical images or by
registering the DWI of all individuals to a prior existing atlas. In the first type of ROI
analysis, regional segmentations from structural (T1w, T2w) MRIs of the same subject
are propagated via linear or deformable co−registration of the structural images to the
diffusion image data and mean statistics are collected [101]. However, the structural
white matter parcellations are commonly lobar based and thus cannot separate the
measurements from different fiber tracts located in the same cortical lobe/region. In
the second type of region of interest analysis co−registration with a prior white matter
fiber atlas is performed [99]. This type of analysis again requires deformable regis-
tration and results in a single measure per fiber region, potentially combining regions
that show significantly different fiber situations. The positive aspects of both of these
types of region based analysis is that processing is relatively simple and it is robust
against imperfect registration. On the other hand, the analysis of large ROIs means
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Figure 2.1: UNC−Utah NA−MIC DTI Framework. Step 1 is Quality Control. Step
2 is Atlas Creation. Step 3 is Interactive Tractography. Step 4 is Parameter Profile
Creation and Statistical Analysis.
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non−specific findings as ROIs can contain multiple fiber tracts and multiple fiber sit-
uations (single, fanning, crossing fiber situations). This form of analysis thus leads to
limited localization of findings.
Another DTI processing framework is voxel based analysis (VBA). This style of
analysis requires registration of each subject into a study specific reference space and
then all voxels are tested individually for significance [124]. While this technique allows
for whole brain analysis and is suitable for hypothesis generation, this analysis assumes
absolutely perfect registration on a voxel by voxel basis and is thus highly sensitive to
the deformable co−registration. Another form of voxel based analysis is FSL’s Tract
Based Spatial Statistics (TBSS). Here a white matter (WM) skeleton is created for the
brain, maximal FA values are projected to the WM skeleton, and voxel wise analysis of
the skeleton is performed [100]. Due to the projection to the WM skeleton, TBSS is less
sensitive to registration accuracy compared to standard VBA. While FSL’s TBSS tool
provides a coherent framework that works well with imperfect registration, it does not
have an explicit tract representation and instead provides a skeletal voxel representation
that cannot be uniquely linked to individual fibers throughout the brain. Further, the
use of maximal FA values renders TBSS sensitive to DWI artifacts.
Our framework falls into the category of quantitative tractography, where anatom-
ically informed curvilinear regions are used to analyze diffusion at specific locations
all along fiber tracts. Diffusion property profiles are computed as weighted averages
taking into account the neighborhood at each step along the fiber bundles [125]. This
form of analysis results in highly localized statistics that can be visualized back on the
individual fiber bundles.
In this paper, we propose the use of our 3D Slicer based UNC−Utah NA−MIC
DTI framework for a coherent atlas fiber tract based DTI analysis. Most steps of the
framework utilize graphical user interfaces (GUI) to simplify interaction and provide
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Figure 2.2: Schematic of DTI processing workflow. The input raw DWI data first un-
dergoes vigorous quality control before the final conversion to DTI for Atlas Building.
Interactive tractography is performed on the Atlas. From these fiber bundles, diffu-
sion parameter profiles are extracted and analyzed along with other study variables to
determine significant correlations.
accessibility for non−technical researchers. At the heart of the framework is a set of
tools anchored around the multi−purpose image analysis platform 3D−Slicer. Several
workflow steps are handled via external modules called from Slicer in order to provide an
integrated approach. Our workflow starts with data conversion from DICOM format,
followed by an automatic as well as interactive DWI and DTI quality control (QC)
steps. Though under appreciated in the field, appropriate and thorough QC is a must
for every DTI study. Our framework then centers around a DTI atlas that is either
provided as a prior template or computed directly as an unbiased average atlas from the
study data via deformable atlas building [125]. Fiber tracts are defined via interactive
label map tractography on that atlas followed by consecutive interactive fiber cleaning
steps. Individual subject DTI fiber tract profiles of FA, MD, RD, and AD are extracted
automatically using the atlas mapping information. These fiber tract profiles are then
analyzed using our statistics toolbox (FADTTS) [126]. The local statistical results are
then mapped back on to the fiber bundles for visualization within 3D Slicer [127].
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This framework has been developed over several years and we continuously improve
the current toolset. Within the past year we have added entropy−based detection
of vibration artifacts as part of the automatic QC and an interactive atlas building
tool called DTIAtlasBuilder. All tools that are part of the UNC−Utah NA−MIC DTI
framework are open source and available on NITRC, providing the neuroimaging field
with a transparent and coherent toolset for DTI fiber tract based analysis.
We illustrate the use of our framework on a small sample, cross sectional neu-
roimaging study of 8 healthy 1 year old children from the Infant Brain Imaging Study
(IBIS) Network (http://www.ibisnetwork.org/UNC). In this paper, we demonstrate
our method by quantifying the diffusion properties within the genu and splenium fiber
tracts. The corresponding raw data, intermediate files, and final results for data pre-
sented in this manuscript have been made freely available on NITRC.
A	   B	  
Figure 2.3: Artifacts encountered during quality control. A.) DWI artifact missed by
automatic quality control run of DTIPrep, but caught in the visual quality control. You
can see the horizontal lines running through this coronal view of the brain. Towards
the top, almost an entire slice is missing. In cases like this, the gradient containing this
artifact would be excluded from the saved DWI volume. B.) Axial and coronal view
of DTI color FA volume. The large area of blue in the left frontal and temporal lobes
indicates that a dominant direction artifact remains after DTIPrep quality control.
Thus this artifact was too large to correct and this participant was excluded from
analysis.
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2.3 Material and Methods
Our framework for the fiber tract based analysis of DTI images is composed of four
essential segments: 1. Quality Control, 2. Atlas Creation, 3. Interactive Tractography,
and 4. Statistical Analysis. The tool workflow can be seen in Figure 2.1 and an
overall conceptual schematic of the process is displayed in Figure 2.2. All of the tools
referenced in the description of our workflow can be utilized as stand−alone command
line applications to facilitate scripting and grid computing, or interactively as part of
3D Slicer as external modules. While the first segment of our framework is termed
Quality Control (QC), it is critical to perform quality assessment of the processing at
every step in the framework to ensure the data that is analyzed is correct.
2.3.1 DWI and DTI Quality Control
DWI Quality Control − DTIPrep
Analysis starts by converting the raw diffusion weighted images (DWI) from DICOM
to NRRD format using a tool called DicomToNrrdConverter in 3D Slicer. This tool is
capable of computing diffusion weighted images via the b−matrix information stored
in Siemens DICOM headers, as well as recognizing many other manufacturer specific
tags. A tool called DTIPrep [102] is then used to check for and correct several common
artifacts found in DWI. In summary, DTIPrep performs image information checking,
slice−wise artifact detection, creates a baseline average, corrects for subject motion and
eddy current induced deformations, and finally detects dominant direction artifacts
[128]. To carry out the automatic QC a protocol must be created that contains all
parameters of the DTIPrep QC. Protocols are fully modifiable for individual studies
and include a significant number of parameters for every step. DTIPrep gives the option
of creating a default protocol from a given scan. On completion of the automatic QC
it is further advised to perform additional visual quality control. Here artifacts that
31
may be missed by the automatic QC step can be detected and gradients still containing
artifacts or motion can be excluded from the final DWI (Fig 3A). After visual quality
control, the DTI tensor and property images are then automatically estimated from
the DWI data via the dtiestim and dtiprocess modules.
DTI Quality Control − 3D Slicer
In addition to checking the DWIs for artifacts, the resulting DTI must also undergo
visual quality control using 3D Slicer. This QC step is to ensure the correct directional
encoding, sufficient signal−to−noise (SNR) in the FA data, and to test the overall
quality of the data by performing landmark−based/fiducial tractography.
Visual DTI QC begins by loading the FA image and scrolling through the slices for
each plane (axial, sagittal, coronal) to assess the apparent level of SNR for the volume.
Next, the DTI volume is analyzed to determine if the header information encoding
directionality for the volume is correct. The DTI image is colored by tract direction
with tracts moving right to left colored red, tracts moving anterior to posterior colored
green, and tracts moving inferior to superior colored blue. The corpus callosum should
appear red, the cingulum green and the corticospinal tract should be blue. Also special
attention is directed to detect dominant directional artifacts if low FA regions (such as
the gray matter) display a single color throughout most of the DTI image, as seen in
Figure 2.3B. Visualization of the primary direction via line glyphs is the next step to
ensure the correctness of the diffusion measurement frame. Glyphs should follow the
direction of the main fiber tracts. If the glyphs are incorrect (due to incorrect DICOM
information or scanner software malfunction), then the corrected measurement frame
must be determined and edited in the volume header.
Once the header information is confirmed to be correct for the volume, fiducial based
32
tractography will provide information whether tractography is feasible, and anatomi-
cally accurate. Fiducial tractography is commonly performed for the major fiber tracts
(corpus callosum (CC) genu and splenium, cingulum, and corticospinal tract) as well
as any tracts of particular interest for the neuroimaging study at hand. In the resulting
fiber tracts, it is important to observe a) sufficient quantity of fibers delineating a fiber
tract, b) whether fibers completely track between the expected terminal regions, and
whether the fiber location is anatomically accurate throughout the length of the fiber
tract. If artifacts remain in the volume, then fibers may break prematurely, appear
warped or incorrectly localized, or if the data has a very low SNR the fiber bundles of
interest may be impossible to track. If tracking is not feasible or anatomically incorrect,
then exclusion of this dataset is suggested.
2.3.2 Atlas Building
Brain Mask Creation, Editing and Application − bet2/AutoSeg
The first step in atlas building is to extract out the brain regions for each DTI
image. To do this, a brain mask must be computed, edited, and applied to the DWIs in
order to create a skull−stripped DTI. Many tools are available for brain mask creation,
such as the Brain Mask from DWI module in 3D Slicer, bet2 within DTIPrep, or a
tissue segmentation based approach in AutoSeg [129]. Brain mask creation by bet2 can
be computed using the baseline image or the IDWI (isotropic DWI), while both are
used jointly to compute the brain mask with AutoSeg. Mask editing is performed also
within 3D Slicer, but any editing tools with Slicer compatible format (NRRD, Nifti,
GIPL, Analyze) can be employed such as itk−SNAP [130]. The edited brain mask can
then be applied to the DWIs, creating a skull stripped DTI (referred to as Original
DTI in this paper) ready for atlas building.
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Figure 2.4: DTIAtlasBuilder steps, GUI, and registration progression. Caption on
following page.
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Atlas Creation − DTIAtlasBuilder
The main atlas building step is performed with a tool called DTIAtlasBuilder, de-
tailed in Figure 2.4. This program allows the user to create an atlas image as an
unbiased average of all co−registered DTI images in the study. Atlases are created
iteratively starting from affine atlases (step 1) and moving to deformable diffeomorphic
atlases (step 2, 3, and 4). The registration is done in three steps: 1) affine registration
with the Slicer General Registration module (called BRAINSFit) [131], 2) unbiased dif-
feomorphic atlas computation [132] with the GreedyAtlas module within AtlasWerks
[132], and 3) a refinement step via symmetric diffeomorphic registration with the Slicer
DTI registration module DTI−Reg using the Advanced Normalization Tools (ANTS)
[133; 134]. The final, refinement step significantly improves registration accuracy in our
experience, most likely attributable to the use of local normalized cross−correlation as
the image similarity metric. A final step will combine multiple transforms to compute
the overall transformation (GlobalDisplacementFields) from the original DTI images
to the Final DTI Atlas. This final transform is required for the analysis of fiber tract
properties in the individual subject space.
Figure 2.4. DTIAtlasBuilder steps, GUI, and registration progression. A.) DTIAtlas-
Builder steps. Black solid arrows indicate transform computation. Blue solid arrows
indicate transform application. Hollow black arrows indicate an averaging of trans-
formed images. Before the Affine registration in step 1, FA is normalized so that FA
intensity difference between subject images does not bias the atlas creation. The FA is
also filtered to remove negative eigenvalues, which will adjust the resulting FA values
to scale between zero and one. The transform computed in step 4 Final Resampling,
Diffeomorphic Transform 4B, is termed the Final (or Global) Displacement Field. It
is this transform that is required to extract fiber tract profiles from each individual
subject DTI when using DTIAtlasFiberAnalyzer later in the workflow. B.) DTIAtlas-
Builder GUI. Here one can see the first tab with the input list of quality controlled
and skull−stripped DTI volumes. Along the top of the GUI, the tabs for adjusting
parameters and tool paths are visible. C.) Progression of the atlas building from a
single participant volume to the affine atlas, and the final unbiased diffeomorphically
registered DTI Atlas in the presented experimental pediatric population.
35
In the first step, DTIAtlasBuilder will generate scalar FA images from the skull
stripped DTIs. The affine atlas building starts by registering subject images to a
pre−exiting FA template in MNI−normative space or to the first subject in case no
prior template is specified. In order to avoid biasing the subsequent analysis, the im-
age intensities are calibrated with the templates intensities using standard histogram
quantile normalization available in ITK. The affine transforms are applied to the orig-
inal DTIs and the transformed images are averaged to create the Affine DTI Atlas
(see Figure 2.4A,B). Each images affine transform is then updated by recomputing the
affine registration in a second loop to the Affine DTI Atlas (rather than to the initial
template as in the first loop). This transform, Affine Transform 1B, is then applied to
the original DTI to create affinely co−registered DTIs for each subject.
In the second step of atlas building, the unbiased diffeomorphic atlas is computed
from the affinely registered FAs via diffeomorphic, fluid flow based atlas building. This
results in deformation fields from the affine space to the unbiased atlas space. These
deformation fields are then applied to the affinely registered DTIs and the transformed
images are averaged to create a Greedy Diffeomorphic DTI Atlas (Figure 2.4A).
The last stage of atlas building utilizes DTI−Reg to refine the diffeomorphic regis-
tration computed in the previous step. To start, FA images from the original subject
DTIs are histogram normalized to the Greedy Diffeomorphic FA Atlas, and then dif-
feomorphically registered to it. The resulting deformation fields are then applied to the
original subject DTI and the resulting diffeomorphically registered DTIs are averaged
to create the Final DTI Atlas. The deformation fields are then updated with another
loop of registrations with DTI−Reg in order to co−register the images with the Final
DTI Atlas (rather than with the Greedy Diffeomorphic FA Atlas as in the first loop).
The overall Global Displacement Fields are finally computed by composing the affine
transform from step 1, as well as the affine and deformation transform from this last
36
step. These displacement fields will be used to map the fiber tracts created in atlas
space to the individual subject spaces for analysis. The final atlas co−registered DTI
images are computed by applying these final deformations fields. It is noteworthy that
this deformation of the DTI images is unlike the processing in TBSS/FSL, where FA
images are deformed. Furthermore, all DTI image interpolations are performed using
standard Log Euclidean based resampling [135].
With the atlas building complete, it is important to perform quality control on
the Affine, Greedy Diffeomorphic, and Final DTI Atlases, simply accessible with a
single button within DTIAtlasBuilder. In this quality control step we can visually
determine the point to point correspondence between the subject images and the atlas
to determine if computed registration transforms are appropriate. The progression of
atlas sharpness can be seen in Figure 2.4C.
Software path configuration for the tool can be performed automatically or manu-
ally, and the settings can be saved for future use. This tool also has a no GUI/command
line option, given that the data file, parameter file, and software configuration file are
available (all can be determined and saved via the GUI). There is also direct support
for the GRID software LSF (Load Sharing Facility, Platform Computing, Inc).
2.3.3 Tractography
Label Map Single Tensor Tractography − 3D Slicer
While atlas building is fully automatic, the definition of fiber tracts of interest needs
to be performed interactively. Fiber tractography only needs to be performed once on
the Final DTI Atlas built in the prior step. In our framework, fiber tractography is
performed via the label map tractography module or the full brain tractography module
within 3D Slicer. If using label map tractography, each fiber tract has a separate
anatomically informed label created in the editor module and is tracked individually
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Figure 2.5: Slicer label map tractography. A.) Sagittal view of the corpus callosum
genu label map in the Final DTI Atlas. B.) Resulting genu bundle fibers from label
map tractography within 3D Slicer. The bundle is colored by FA values along the fibers
with cooler colors indicating higher FA.
(Figure 2.5). Alternative fiber tracking tools can be employed as long as the resulting
fibers are stored in standardized vtk−based file format. Resulting DTI fiber bundles
require post−processing via ROIs to remove unwanted, erroneous fibers.
Coarse fiber bundle editing with ROIs − 3D Slicer
The results of label map tractography may contain fibers in addition to the fiber
bundle of interest. Coarse cleaning is performed with interactive 3D regions of interest
(ROIs) in 3D Slicers tractography display module. Here fibers to be kept or removed
are selected using ROIs iteratively. ROIs should also be utilized for separating tracts
that run within the left and right hemispheres in order to allow separate analysis of
the right and left portions (for example the left and right hemispheric portions of the
fornix).
Fine fiber bundle editing − FiberViewerLight
Fiber tracts often need additional, finer editing via clustering and cleaning within
FiberViewerLight. Fiber length based cleaning and several fiber clustering algorithms
38
A	   B	  
Figure 2.6: FiberViewerLight clustering, cleaning, and plane creation. A.) Example of
genu fiber clustering based on the center of gravity. B.) In the left panel all of the fiber
clustering algorithms are visible, as well as the different styles of computation (Classic
vs Danielsson). In the right panel the plane function is visualized for the genu. This
tool is used to set a plane of origin from which the fiber bundle will be parameterized
for further analysis.
(center of gravity, Hausdorff distance, mean distance, normalized cut) to further delin-
eate which fibers belong in the bundle of interest and which ones do not (Figure 2.6).
The decision for inclusion or exclusion is based on expected fiber tract anatomy. Once
fiber bundles are deemed appropriate, diffusion property profiles for each fiber tract
and subject image are extracted as described in the next section.
2.3.4 Property profiles and statistical analysis
Diffusion Property Profiles − DTIAtlasFiberAnalyzer
As a final step prior to statistical analysis, diffusion properties along the fiber tracts,
called fiber property profiles, are extracted. For that purpose, a fiber tract parameter-
ization needs to be established, which is achieved via arclength parameterization [136]
starting from each fibers intersection with an origin plane. While DTIAtlasFiberAn-
alyzer automatically determines an appropriate origin plane, investigators can choose
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to interactively determine that plane in order to associate a specific anatomical fiber
location to this origin within FiberViewerLight (see Figure 2.6B).
The parameter profile generation and processing is performed with a tool called
DTIAtlasFiberAnalyzer, shown in Figure 2.7. The profile extraction operates on the
original DTI data in order to avoid the need for tensor deformation by deforming the
parameterized fibers into original space via the previously computed Global Deforma-
tion Field. At the deformed fiber locations the tool can then calculate the different
fiber property profiles along each fiber in the bundle (FA, RD, AD, MD, GA, Fro, λ2,
and λ3) in subject space. Figure 2.7B shows example FA profiles of the genu calculated
and visualized with DTIAtlasFiberAnalyzer for this study. Visualization of these fiber
property profiles for each subject versus the fiber bundle in atlas space allows an alter-
native assessment of the registration quality to atlas space (Figure 2.7B). Inspecting
the atlas fiber bundle parameterization is an additional quality control step to confirm
correct parameterization (Figure 2.7C). An error in parameterization usually requires
a change in origin plane to correct the problem.
The fiber property profiles are the input for the analysis tool called Functional
Analysis of Diffusion Tensor Tract Statistics (FADTTS) [126] that performs statistical
analysis on the fiber bundle profiles. This tool has the ability to compute group dif-
ference and correlational analyses (Figure 2.8). Currently the FADTTS tool is Matlab
(MathWorks Inc, MA) based, and requires a user familiar to Matlab to operate. The
Matlab scripts used to analyze the data for this paper are available with the sample
data at www.nitrc.org.
Statistical Analysis of Diffusion Properties Along the Fiber Tract − FADTTS
Using the diffusion profiles obtained from DTIAtlasFiberAnalyzer, it is possible to
test how these diffusion properties relate to other variables of interest within the sample
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Figure 2.7: DTIAtlasFiberAnalyzer GUI. Caption on following page.
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data. FADTTS performs several statistics tests including a multi−variate coefficient
model, weighted least squares estimation, and functional principal component analysis.
These tests produce both global and local test statistics with confidence bands and the
local values are corrected for multiple comparisons with false discovery rate (FDR).
Several statistical plots are commonly created, a sample of which can be seen in Figure
2.8. From the beta plots, the direction, magnitude, and significance of the relationship
of interest can be assessed by the beta sign, distance from zero, and the significance
marker (a filled circle) on the curve respectively (Figure 2.8C,D).
Mapping covariate p−values on fiber bundles for visualization − MergeS-
tatWithFiber
Upon computation of test statistics with FADTTS, the statistics can be mapped
to their corresponding location on the fiber bundle using a tool called MergeStatWith-
Fiber. The input for MergeStatWithFiber is the comma−separate−value (csv) file re-
sulting from FADTTS with the addition of arclength as the first column, and a header
row containing column labels. The result of this merge is then visualized in 3D Slicer
(Figure 2.8E). The color map shown is determined by the significance threshold set in
MergeStatWithFiber, as such that all points on the fiber that have a p−value above
Figure 2.7. DTIAtlasFiberAnalyzer GUI. A.) In the first tab of this tool the input data
is defined: the label for each participant, the original quality controlled skull−stripped
DTI, and the GlobalDeformationField computed in Atlas Building. B.) After DTIAt-
lasFiberAnalyzer has sampled the intended diffusion parameters, DTI property profiles
for individual images (green) and the DTI atlas (blue) can be visualized in the Plot
Parameters tab. Inspecting these profiles allows for a different type of quality control
of the atlas registrations. The FA profiles of the subjects (pictured here) should be sim-
ilarly shaped to the atlas. C.) Visualization of the parameterized genu and splenium
fibers in the axial and sagittal views. Fibers that have been correctly parameterized
with DTIAtlasFIberAnalyzer via the origin plane will be colored by FiberLocationIn-
dex (arclength) from red to blue. Red indicates low arclength and blue high arclengths.
The corresponding profile plots of these genu and splenium fibers would run from the
right to the left hemisphere.
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Figure 8.  Examples od possible plots 
from Functional Analysis of Diffusion 
Tensor Tract Statistics (FADTTS) and 
MergeStatWithFiber.  A. Plot raw data. 
B. Output of FDR corrected local –log  
p-values along the length of the fiber 
tract .  C. Separate beta plots for all of 
the covariates entered into the model 
and how they interact with each 
diffusion parameter.  D. Separate beta 
plots for how all the investigated 
diffusion parameters interact with each 
covariate in the model. For both beta 
plots, the filled in circles along the lines 
indicate areas of significance post FDR 
correction. E. Visualization of local 
statistics along the tract with 3D Slicer. 
Specifically this image reflects the 
corrected local p-values for the 
interaction between Age and FA for the 
genu (C. blue line, D. red line). All non-­‐
signiﬁcant	   points	   are	   assigned	   a	   single	  
value	  and	  color	  (dark	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  here).	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Figure 2.8: Examples of possible plots from Functional Analysis of Diffusion Tensor
Tract Statistics (FADTTS) and MergeStatWithFiber. Caption on following page.
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the significance threshold are colored blue, and all points with values below the signif-
icance threshold are colored from cyan to red, with points indicated in red signifying
the areas of greatest significance. If desired, this color map can be altered within Slicer
to another color table. MergeStatWithFiber can be used as a command line tool or
through the final tab in the DTIAtalsFiberAnalyzer GUI (Figure 2.7).
2.4 Results
For our example data we created an unbiased diffeomorphic atlas with eight 12
month old IBIS participant scans, and performed interactive tractography of the genu
and splenium on this atlas. Diffusion parameter profiles were created for these two
fiber bundles and these profiles were further analyzed with FADTTS. While each of
the participants were categorized as 12 month olds for the IBIS study, the correlation
between a subjects actual age in months (ranging from 11.8 to 14.5 months) and the DTI
properties was analyzed to illustrate the use of our tools. On the genu, 3 areas showed
significant correlation between Age and FA, but no areas of significant correlation were
found on the splenium (data not shown). Figure 2.8C shows the graphical output of
this result from FADTTS in the blue line for Age with the filled in circles indicating
Figure 2.8. Examples of possible plots from Functional Analysis of Diffusion Tensor
Tract Statistics (FADTTS) and MergeStatWithFiber. A.) Plot the raw data. B.) Out-
put of FDR corrected local log p−values along the length of the fiber tract. C.) Separate
beta plots for all of the covariates entered into the model and how they correlate with
each diffusion parameter. D.) Separate beta plots for how all the investigated diffu-
sion parameters correlate with each covariate in the model. For both beta plots, the
filled in circles along the curves indicate areas of significance post FDR correction. E.)
Visualization of local statistics along the tract with 3D Slicer. Specifically this image
reflects the corrected local p−values for the correlation between Age and FA for the
genu (C. blue line, D. red line). All non−significant points are assigned a single value
and color (dark blue here). Points that are significant then proceed from the next value
on the color bar until the furthest end of the color bar. In the color bar shown, areas of
significance are colored from cyan to red, with red areas indicating most significance.
Any color bar available can be used.
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significance. Figure 2.8E portrays the same information of significance mapped back
on to the original genu fiber bundle.
2.5 Discussion and Conclusion
With the use of diffusion tensor imaging on the rise, the field of neuroimaging is
in need of a coherent paradigm for localized fiber tract based diffusion tensor imaging
(DTI) analysis. Here, we illustrate the UNC−Utah NA−MIC framework for DTI fiber
tract analysis assessing the genu and splenium in one year olds from the UNC arm of
the IBIS study. To demonstrate the use of our framework we analyzed the relationship
of subject age in months with diffusion tensor properties. For the genu there were three
locations of significant correlation as visible in Figure 2.8. The splenium demonstrated
no areas of significant correlation. To facilitate utilization of our workflow, all of the
data, intermediate files, scripts, and tools are freely available on NITRC.
Over the past few years we have created and tested our tools to provide maximum
usability and a detailed analysis of diffusion at each point along fiber bundles. As these
are tools for research, the tools in our framework are constantly evolving as we improve
their function and incorporate new options. For example, we are currently enhancing
DTIPrep to allow for simulation based error estimation, enhancing DTIAtlasBuilder
to improve its unbiased atlas building step, as well as providing a GUI (non−Matlab)
based interface to FADTTS directly within DTIAtlasFiberAnalyzer.
While all tools employed here are individually available online (see appendix below),
all needed modules of this framework are directly available for download via the 3D
Slicer extension manager (version 4.3 and above) (Figure 2.9). We hope our workflow
will fill the void in the field for the many neuroimaging investigators that need to
analyze their DTI data with a localized fiber based approach.
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Figure 2.9: A screenshot displaying our tools as available extensions in 3D Slicer (box
highlighted to indicate our Slicer modules).
2.6 Software and Example Dataset
3D Slicer: http://www.slicer.org
DTIPrep: http://www.nitrc.org/projects/dtiprep/
AutoSeg: http://www.nitrc.org/projects/autoseg/
itk−SNAP: http://www.itksnap.org/pmwiki/pmwiki.php
DTIAtlasBuilder: http://www.nitrc.org/projects/dtiatlasbuilder/
MriWatcher: http://www.nitrc.org/projects/mriwatcher/
AtlasWerks: http://www.sci.utah.edu/software/13/370$-$atlaswerks.html
DTI−Reg: http://www.nitrc.org/projects/dtireg/
BRAINS: http://www.nitrc.org/projects/brains/
ANTS: http://www.picsl.upenn.edu/ANTS/
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FIberViewerLight: http://www.nitrc.org/projects/fvlight/
DTIAtlasFiberAnalyzer: http://www.nitrc.org/projects/dti_tract_stat
FADTTS: http://www.nitrc.org/projects/fadtts/
Matlab: http://www.mathworks.com/products/matlab/
Dataset: http://www.nitrc.org/projects/namicdtifiber/
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CHAPTER 3
WHITE MATTER MICROSTRUCTURE ABNORMALITIES IN THE
FORNIX AND CINGULUM OF CIGARETTE SMOKERS: A
TRACTOGRAPHY BASED ANALYSIS
1
3.1 Introduction
Fifty years after the 1964 surgeons generals report on Smoking and Health, cigarette
smoking is still the single most preventable cause of death worldwide, killing almost
6 million people each year [1]. In the US alone cigarette smoking is responsible for
1 in every 5 deaths; more than all other drug deaths combined [3; 5; 4]. Despite
approximately 70% of cigarette smokers wanting to quit and 50% trying to quit each
year, only 5% are successful in their cessation 1 year from their quit date [9]. To
improve the success rate of cessation attempt, more effective therapies are needed. A
better understanding of the neurobiology of cigarette addiction may help in creating
more effective therapies.
A promising approach to this issue is to investigate the neural bases of intermediate
phenotypes for smoking addiction. For instance, a growing focus in this intermediate
phenotype approach to addictive disorders is the tendency to more often select smaller,
sooner over larger, delayed rewards [137], a characteristic of cigarette among smokers
1This chapter is in preparation for submission to NeuroImage Clinical
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[56; 57; 58]. Such delayed reward discounting is a feature of addiction that may criti-
cally play into the cycle of quit attempt and relapse. Excessive discounting of delayed
rewards can be reduced by engaging in episodic prospection during decision−making
in healthy people, an effect mediated by enhanced synchrony between medial temporal
lobe regions implicated in episodic prospection and medial prefrontal areas implicated
in decision−making [80; 81]. As such, we hypothesized that smokers would show struc-
tural abnormalities in the white−matter tracts through which these brain areas com-
municate: the cingulum, fornix, and uncinate. We investigated this hypothesis using a
novel framework for diffusion tensor imaging (DTI) tractography based analysis [84].
DTI captures the diffusion of water molecules within brain tissue via several dif-
fusion parameters: fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity
(RD), and mean diffusivity (MD). FA is used as a measure of overall white matter mi-
crostructure integrity, describing the extent to which diffusion of water is linear along
a fiber bundle as compared across the fiber. The primary eigenvalue, AD, is the com-
ponent of FA that describes diffusion along the length of the fiber bundle, whereas
an average of the second and third eigenvalues, RD, describes diffusion orthogonal to
the length of the fiber bundle. MD is an average of the first three eigenvalues and
characterizes the overall magnitude of diffusion. Axial diffusivity is known to decrease
in the case of neuron death, while RD increases in settings of myelin damage [98]. An
alteration in FA can be caused by changes in fiber bundle organization, myelination,
cell death, or inflammation.
To date, few studies have investigated how cigarette smoking independently affects
white matter (WM) integrity in the brain using DTI. Studies to date have primarily
utilized voxelwise analysis, including Tract−based Spatial Statistics (TBSS) [100], or
relatively large, nonspecific regions of interest (ROI) analyses. To date, none have
performed analyses along WM fiber tracts. Thus, previously reported DTI findings
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in smokers are not truly localizable to specific tracts or exact locations along a tract.
Moreover, when comparing smokers to nonsmokers using the above mentioned DTI
analysis techniques, findings have been mixed. While most studies have reported in-
creased FA in the brains of smokers compared to nonsmokers [103; 104; 105; 106; 107],
others have found decreased FA among smokers [108; 109], or no difference in FA be-
tween smokers and nonsmokers [110; 111]. Likewise a variety of conclusions have been
drawn as to how cigarette consumption and addiction severity relate to WM integrity
in smokers. Some studies have found a negative correlation between measures of ad-
diction severity and FA [104; 110; 106; 107], while others have observed a positive [103]
or no [105; 109] correlation.
Several factors may contribute to these discordant findings, one of which is the use
of nonspecific voxelwise or ROI−based analyses. With these analysis techniques, single
average measurements of diffusion parameters (FA, MD, RD, AD) are used to represent
regions that may encompass multiple WM tracts, or even contain both WM and grey
matter. In order to better understand how cigarette smoking addiction affects WM
integrity, here we applied a more specific and localizable WM fiber based technique.
Using DTI data collected from current cigarette smokers and non−smoking controls,
we investigated the WM microstructural integrity of tracts implicated in the processes
of episodic prospection and decision making: the cingulum, fornix, and uncinate. The
goal of this investigation is to answer two questions: Does WM microstructural integrity
differ between smokers and non−smokers along these tracts? Within smokers, does
WM microstructural integrity differ as a function of measures of smoking dependence
(cigarettes/day, CO, Cigarette Dependence Scale)? To address these questions, we
performed DTI tractography, creating anatomically specific curvilinear ROI, analyzing
the diffusion properties at each millimeter along the fiber bundle, a novel method of
analysis for the cigarette addiction field.
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Participants
Mean / % SD (Range) Mean / % SD (Range) p-value
Age (years) 25.4 7.4 (19-40) 23.4 3.6 (19-29) 0.376
Sex (% Female) 50% 40% 0.697
Ethnicity (% Caucasian) 70% 47% 0.414
Education (years) 14.8 2 (12-18) 16.6 2.5 (12-21) 0.055
Smoking Measures:
Average Cigarettes/Day 13.9 6.5 (5-25)
CO concentration (parts/million) 13.3 11.6 (0-34)
Cigarette Dependence Scale 42.2 11.1 (27-59)
Age of Onset 17.5 2.5 (13-22)
Years Smoking 7.9 7.5 (1-25)
Table 1  Participant demographics and smoking measures
Smokers (n=10) Nonsmokers (n=15)
Table 3.1: Participant demographics and smoking measures. CO = carbon monoxide,
SD = standard deviation.
3.2 Methods
3.2.1 Participant sample and demographics
Participants were recruited from the University of North Carolina at Chapel Hill
(UNC) and surrounding areas by advertisement. Participants were all healthy, right−handed,
native English speakers, 18−40 years old, without a known history of disorders of the
nervous system, psychoactive medications, or contraindications to magnetic resonance
imaging (MRI). Non−smokers reported no past or current regular smoking, and smokers
were defined by self−reported smoking of ≥ 5 cigarettes per day. Participants provided
written informed consent as approved by the UNC Office of Human Research Ethics,
and received monetary compensation for participating. We acquired diffusion weighted
images (DWI) from 29 participants, 15 non−smokers and 14 smokers. Data from
n=4 smokers were excluded due to artifacts and low signal to noise ratio in the DWI
data. Thus all analyses reported here derive from 25 participants (15 non−smokers,
10 smokers). The groups did not differ significantly by age, sex, or ethnicity, but the
non−smokers did have an average of almost two additional years of education (p =
0.05; Table 4.1).
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3.2.2 Measurements
Smokers were instructed to smoke as usual on the day of the scan. Prior to scan ac-
quisition participants completed questionnaires and provided a breath carbon monoxide
(CO) measurement. The questionnaires included a lab developed questionnaire about
smoking habits [138] and the Cigarette Dependence Scale (CDS; [55]). We chose the
CDS over the more frequently employed Fagerstrom Test for Nicotine Dependence
(FTND), as evidence demonstrates that the CDS performs better than the FTND on
measures of construct and predictive validity [53; 54].
3.2.3 Magnetic resonance imaging
All MRI scans were acquired on a head−only 3T Siemens Allegra scanner (Siemens
Medical System, Erlangen, Germany). A single−shot echo−planar DTI sequence was
used to acquire diffusion weighted images (DWI) using the following parameters: TR =
1000 ms, TE = 88 ms, slice thickness = 2 mm, in−plane resolution = 2 x 2 mm2, and
66 slices; total duration = 10.67 min). 63 separate images were acquired for each DTI
scan: 9 images without diffusion sensitization (b = 0 images) and 54 diffusion weighted
images along unique gradient directions (b = 1000 s/mm2).
3.2.4 Image analysis framework
Raw DWI images were processed and DTI tractography analysis was performed
using the UNC−Utah NA−MIC Framework for DTI Fiber Tract Analysis Verde2014,
which is schematized in Figure 3.1. In brief, DWI images first underwent rigorous qual-
ity control, eddy current, and motion correction with DTIPrep2 [102; 128]. We next
evaluated DTI signal to noise and tractography feasibility using 3D Slicer [127]. Here it
was discovered that the right−left glyph direction was flipped, and image measurement
2http://www.nitrc.org/projects/dtiprep
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Figure 3.1: UNC−Utah NA−MIC framework for DTI fiber tract analysis. The frame-
work begins with rigorous quality control of individual participant data inspecting for
DWI artifacts (1), DTI direction encoding (2), glyph orientation (3), and landmark
(fiducial) tractography. Together these steps correct common DWI artifacts, assess
data quality, and tractography feasibility. Quality controlled DTI from each partici-
pant is then used to create a study specific DTI atlas via linear and nonlinear regis-
tration. On this atlas, fiber bundle tractography is performed. Fiber tracts are then
cleaned and parameterized so each location along the tract has a relative address. Then
diffusion parameters at each address along the tract are extracted from native space
for individual participants, creating diffusion parameter profiles for each tract. These
profiles are then entered into statistical analysis. Resulting p−values and/or betas can
then be visualized on the fiber bundle.
frames were edited in the original DWI header file to correct this directionality for all
participants. Then DWI and DTI quality control was repeated with the correct mea-
surement frame. Brain masks were created from the b=0 (b0) images and the isotropic
diffusion weighted (IDWI) images with AutoSeg3 [129], and edited in ITK−SNAP4
[130]. A study specific atlas was then built using linear, unbiased diffeomorphic, and
symmetric diffeomorphic registrations of skull−stripped DTIs as detailed in [84]. We
next performed interactive fiber tractography for the bilateral cingulum, fornix, and
3http://www.nitrc.org/projects/autoseg/
4www.itksnap.org
53
Fornix 
Uncinate 
Body 
Crus 
Fimbria 
Columns 
Temporal 
Frontal 
Cingulum 
Body 
Posterior 
Anterior 
A D C B Posterior  
Frontal 
Figure 3.2: Fiber tracts analyzed and anatomical definitions. A. Fiber bundles of
interest are represented in their anatomical location in a glass brain, with the cingulum
in blue, the fornix in pink, and the uncinate in green. B−D display the individual
fiber bundles with locations along the tract labeled to clarify findings. These fibers are
colored by the parameterized addresses along each tract (arclength). B. Cingulum, C.
Fornix, and D. Uncinate.
uncinate on the Final DTI Atlas in 3D Slicer. See Figure 3.2 for anatomical orienta-
tion of each tract investigated. We executed gross fiber bundle cleaning in 3D Slicer
utilizing ROIs, followed by fine scale clustering based processing in FiberViewerLight5
. In order to analyze only the properties of the main fiber bundle, cortical projections
were removed from the cingulum bundle using the cutter option in FiberViewerLight.
A fiber origin plane was then manually placed for each fiber bundle for tract spatial
parameterization, i.e. defining the corresponding arclengths per fiber [139]. Diffusion
properties along each tract were extracted for each individual participant employing the
final transform computed during atlas building using DTIAtlasFiberAnalyzer6. Within
DTIAtlasFiberAnalyzer, these diffusion parameters are then plotted as diffusion pro-
files along the length of each tract, and FA profiles were visually quality controlled
for participant profiles with poor correlation to the atlas FA profile. An example of
FA profile plots for all participants is displayed in Figure 3.3, which depicts the left
and right fornices. Diffusion parameter measurements were then statistically analyzed
via Functional Analysis of Diffusion Tensor Tract Statistics (FADTTS)7 [126]. Local
5http://www.nitrc.org/projects/fvlight
6http://www.nitrc.org/projects/dti_tract_stat/
7https://www.nitrc.org/projects/fadtts/
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Figure 3.3: Participant fornix fractional anisotropy (FA) profiles. Measurements of FA
along the tract for all participants in the left (A) and right (B) fornices. FA profiles are
plotted in the middle panels, with nonsmokers indicated in blue, and smokers indicated
in red. The color bar on the x axis of the FA profile plots corresponds to the location
along the left or right fornix, as depicted in the outer panels. M− medial, T− temporal.
p−values and betas computed with FADTTS were plotted onto the fiber bundle and
visualized in 3D Slicer or ShapePopulationViewer8.
Tractography ROIs
Region of interest label maps for use in the tractography of each tract were based on
tract anatomy. Label maps for each tract were manually constructed to be inclusive,
but specific for individual tracts. Left and right tract label maps were created at the
same time in Slicer, using unique label identifiers. Simultaneous label creation aids in
assuring the bilateral consistency of the label map extent for each tract.
Tractography algorithm
Tracts were seeded in 3D Slicer using label maps as described above. Tracks between
10mm and 800mm were computed with a seed spacing of 0.5mm, stopping FA value of
0.18, stopping curvature of 0.7mm, and step length of 0.5mm. Tracts were then cleaned
utilizing negative and positive ROIs until only the fibers of the desired tract remained.
8http://www.nitrc.org/projects/shapepopviewer/
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3.2.5 Statistical analysis
For between group comparisons, we used Students t−tests for continuous measures,
and χ2 tests for dichotomous variables. We used FADTTS to analyze the relation-
ship between diffusion parameters and variables of interest at each millimeter along
the fiber bundles [126]. FADTTS is composed of several steps: multivariate varying
coefficient model, weighted least squares estimation, functional principal component
analysis, hypothesis testing (with wild bootstrapping) for global and local test statis-
tics, confidence band computation, false discovery rate (FDR) correction of omnibus
local test statistics, and posthoc analysis for individual diffusion parameter significance
assessment with false discovery rate correction of local test statistics. For each model,
a single variable of interest was investigated while controlling for effects of age and sex.
3.2.6 Result visualizations
The FADTTS plots included in this manuscript depict beta magnitudes for each
diffusion parameter (FA− green, RD− red, AD− blue, MD− magenta) along the length
of the fiber tract for each variable of interest. Although included in our correction for
multiple comparisons, diffusion correlations for the terminal 6mm of all fiber bundles
were disregarded (denoted by grey rectangles at plot edges), as diffusion parameters
extracted at fiber ends are considered less reliable. The fiber bundle figures map the
significant FA beta locations on the left and right tracts. Coloration for the fiber
tract figures is by significant FA effect magnitude and direction for each tract, where
non−significant areas along the tract are shown in grey.
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Figure 3.4: Smokers have decreased microstructural integrity in bilateral fornix crus
and body. Effect of Group on white matter integrity in the left fornix (A) and right
fornix (B). Medial plots depict diffusion parameter beta values for the effect of Group.
Positive betas indicate higher diffusion parameter values among smokers. Filled circles
indicate significant correlations after FDR correction. Lateral panels localize the sig-
nificant findings for FA. Cool colors indicate decreased FA among smokers compared to
nonsmokers. FA− fractional anisotropy, RD− radial diffusivity, AD− axial diffusivity,
MD− mean diffusivity, M− medial, T− temporal.
3.3 Results
3.3.1 Group differences in white matter microstructure
White matter microstructure integrity is decreased in the body and crus of the left
and right fornix of cigarette smokers when compared to non−smokers (Figure 3.4).
While there is a significant difference between groups when considering all diffusion
parameters together, posthoc tests of individual diffusion parameters did not find any
significant group effects. In addition to these findings in the fornix, we also observed
sporadic areas of significant group difference in the bilateral cingulum and uncinate.
However, the effect sizes for these findings were minimal, with abundant sign reversals,
precluding robust interpretation (data not shown). As detailed in the following sections,
we next analyzed the relationship between WM integrity in the same tracts of interest
and measures of cigarette consumption and addiction severity within the smokers.
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Figure 3.5: White matter integrity in smokers positively correlates with cigarettes per
day. Relationship between cigarettes per day and WM in the left fornix (A), right fornix
(B), left superior cingulum (C), and right superior cingulum (D). Plots depict beta
values for the correlation between cigarettes per day and WM diffusion parameters.
Positive beta values indicate a positive correlation with cigarettes per day and the
indicated diffusion parameter. Filled circles indicate significant correlations after FDR
correction. The tract panels render FA beta values spatially localized to sites along the
tract where WM diffusion significantly correlated with cigarettes per day. Coloration
conventions as for Figure 4. FA− fractional anisotropy, RD− radial diffusivity, AD−
axial diffusivity, MD− mean diffusivity, M− medial, T− temporal, A− anterior, P−
posterior.
3.3.2 WM and measures of cigarette consumption
WM and self reported cigarette consumption
Given the findings reported above, to our surprise, WM microstructure integrity
in the bilateral fornices positively correlated with self−reported number of cigarettes
smoked per day (Figure 3.5A, B). In other words, WM integrity increased with increas-
ing intensity of cigarette smoking. This result was most evident in the left and right
fornix body, crus and fimbria. Moreover, we observed the same relationship between
self−reported cigarettes per day and WM integrity in the left and right cingulum body,
and left anterior cingulum (Figure 3.5 C, D).
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Figure 3.6: White matter integrity in smokers positively correlates with exhaled carbon
monoxide (CO). Effect of CO on white matter integrity in the left fornix (A), right
fornix (B), left superior cingulum (C), and right superior cingulum (D). Plots depict
diffusion parameter beta values for the effect of CO. A positive beta indicates a positive
correlation between CO and diffusion property, a negative beta indicates a negative
correlation. Significant correlations are indicated by filled circles. The figures map
the respective significant beta locations for FA. Coloration for the figures is by relative
FA beta magnitude and effect direction. Cool colors indicate a negative correlation;
warm colors indicate a positive correlation. FA− fractional anisotropy, RD− radial
diffusivity, AD− axial diffusivity, MD− mean diffusivity, M− medial, T− temporal,
A− anterior, P− posterior.
WM and a biological measure of consumption: exhaled CO
While self−reported cigarettes per day provides a widely employed and useful mea-
sure of smoking habit intensity, variations in the type of cigarettes are smoked and
the manner in which they are smoked can introduce significant variation between indi-
viduals reporting identical numbers of cigarettes smoked per day [140]. We therefore
also assessed the relationship between measures of WM integrity and exhaled CO levels
among smokers. We found that exhaled CO positively correlated with WM microstruc-
ture integrity in the left fornix body and fimbria (Figure 3.6A), as well as in the left
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and right cingulum anterior and body (Figure 3.6C, D). In other words, those with
higher biological measures of smoking intensity on the day of the scan had increased
WM tract integrity in these locations. Notably, we did not observed a significant rela-
tionship between WM integrity and exhaled CO in either the left or right fornix crus,
with betas suggesting the opposite relationship between WM integrity and exhaled CO,
compared to cigarettes/day, in these regions.
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Figure 3.7: White matter integrity in smokers positively correlates with Cigarette De-
pendence Scale (CDS). Effect of CDS on white matter integrity in the left fornix (A),
right fornix (B), left superior cingulum (C), and right superior cingulum (D). Plots
depict diffusion parameter beta values for the effect of CDS. A positive beta indicates
a positive correlation between CDS and diffusion property, a negative beta indicates
a negative correlation. Significant correlations are indicated by filled circles. The fig-
ures map the respective significant beta locations for FA. Coloration for the figures is
by relative FA beta magnitude and effect direction. Cool colors indicate a negative
correlation; warm colors indicate a positive correlation. FA− fractional anisotropy,
RD− radial diffusivity, AD− axial diffusivity, MD− mean diffusivity, M− medial, T−
temporal, A− anterior, P− posterior.
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3.3.3 WM and cigarette dependence
While self−reported cigarettes per day and exhaled CO each provide quantitative
measures of heaviness of smoking, which is related to cigarette dependence, heaviness
and dependence (or addiction) are not perfectly correlated. As such we also investigated
the relationship between WM microstructure integrity and a quantitative measure of
cigarette addiction: Cigarette Dependence Scale (CDS) scores. We observed positive
correlations between WM integrity and CDS scores within the left and right fornix
crus and fimbria, the bilateral cingulum body, and the left anterior cingulum (Figure
3.7). These findings showed better correspondence with the self−reported cigarettes
per day associations with WM than did WM associations with CO, and supports the
interpretation that among smokers more severe cigarette addiction is associated with
more intact WM microstructure.
3.3.4 Summary of Findings
White matter integrity is decreased in smokers compared to nonsmokers in the
fornix crus and body bilaterally. Within smokers, white matter integrity of the fornix
crus and body bilaterally positively correlates with cigarettes smoked per day and
CDS scores. Within smokers, white matter integrity of the cingulum anterior and
body bilaterally positively correlates with cigarettes smoked per day, exhaled carbon
monoxide concentration, and CDS scores. Results for the uncinate were of minimal
effect size and contained multiple sign reversals inhibiting robust interpretation for
both between group and within smokers analyses.
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3.4 Discussion
3.4.1 Differences between smokers and nonsmokers
To our knowledge, this is the first investigation of WM diffusion parameters compar-
ing cigarette smokers and non−smokers that allows localization of effects along specific
fiber tracts. Previous DTI studies in cigarette smokers relied upon voxelwise or ROI
based analyses; these less specific techniques may have contributed to the mixed find-
ings in the literature. As can be seen in Figure 3.3, group effects on diffusion properties
vary along the length of the tracts, underlining the utility of a more localized and
specific form of DTI tractography analysis.
While most previous studies of smokers have found increased WM integrity, as
measured by FA, in smokers compared to non−smokers, here we found smokers to have
decreased WM integrity in bilateral fornix body and crus compared to nonsmokers.
It is important to note, however, that this is the first published report comparing
WM microstructural integrity in the fornix between smokers and nonsmokers. We
also note that although the omnibus tests of group differences in diffusion parameters
within the fornix crus and body were significant, large magnitude effects, the posthoc
analysis of independent diffusion parameters did not identify significant group effects,
indicating that the omnibus group effects were not driven by an individual diffusion
parameter, but by collective effects across parameters. Thus, the group differences in
WM integrity reported here may reflect a combination of changes in myelination, cell
death, inflammation, and fiber bundle organization.
Theoretical role for the fornix in cigarette addiction
The fornix is a part of the limbic circuitry and is implicated in episodic memory,
networks that may play an important role in addiction [141? ; 83]. Previous work
has found episodic memory to be disrupted in deprived smokers [82], and the same
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circuit used in episodic memory is utilized in episodic prospection. The ability to
vividly imagine future outcomes in a detail rich manner is known to impact decisions
between alternate outcomes [80; 81], a process crucial to the behavioral change neces-
sary for addiction cessation. As such, abnormalities in the circuitry supporting episodic
prospection could theoretically hinder smoking cessation and undermine certain behav-
ioral cessation therapies. Further, the fornix plays a role in addiction as it connects the
hippocampus to the nucleus accumbens, a structure well documented for its role in the
reward processing of addiction [142; 143]. Additionally, it has been documented that
smokers have decreased hippocampal volumes bilaterally compared to nonsmokers, and
that hippocampal volumes decreased with increased pack/yrs [115]. As the fornix is
the main projection of the hippocampus, it is within reason to think there may also be
a difference in the fornix of smokers and nonsmokers.
3.4.2 Findings within smokers
As the primary difference between groups was in the fornix body and crus bilaterally,
it is this location that was focused on initially in our within smokers investigation.
Additional examination of the cingulum and uncinate bilaterally were also pursued.
It is noteworthy, that this is the first study to perform correlational analysis between
white matter microstructural integrity and addiction severity measured with the CDS.
All prior DTI studies have used the FTND to assess addiction severity; a measure
with reduced validity regarding construct and prediction when compared to the CDS
[55; 53; 54]. Further, only one prior study has found a positive correlation between
white matter integrity in smokers and cigarette consumption as measured by pack/years
[103]. Most other studies find either a negative correlation [104; 110; 106; 107], or no
correlation at all [105; 109].
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Fornix body and crus integrity positively correlate with cigarette consump-
tion and addiction severity
Both cigarettes/day and CDS scores positively correlated with white matter in-
tegrity in the fornix body and crus. The relationship between CDS scores and WM
integrity best matched the location the between groups results were found in, and had
the greatest magnitude effect of all analyses performed. This suggests that this in-
crease in white matter integrity with increasing addiction severity is more a function
of the addiction process overall and not just a reflection of consumption. This is sup-
ported by the fact that the biological measure of consumption, CO, showed little to no
relationship with white matter integrity in the fornix crus bilaterally for smokers.
One prior study has found smokers who relapsed had larger bilateral hippocampi
compared to those smokers who maintained abstinence [144]. This may suggest that the
more addicted smokers have larger hippocampi, and this may translate to an increase
in integrity in the fornix of the most addicted smokers.
Cingulum anterior and body integrity positively correlate with cigarette
consumption and addiction severity
In the cingulum bilaterally, white matter microstructural integrity positively corre-
lated with both measures of consumption (cigarettes/day and CO) and the measure of
addiction severity (CDS). These relationships occurred in the cingulum body and ante-
rior, and were of greatest magnitude in the left cingulum. Unlike findings in the fornix
of smokers, the cingulum findings are all of similar magnitude, but the largest bilateral
effect is that of CO. The anterior cingulate cortex has one of the highest densities of
nicotinic acetylcholine receptors (nAChRs) in the brain, and maybe this receptor den-
sity could cause this region of the cingulum to be particularly sensitive to the effects
of recent cigarette consumption as measured by CO concentration [145].
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Our results in the cingulum are in conflict with prior DTI literature where smok-
ers were found to have higher white matter integrity (FA) in the anterior cingulum
when compared to nonsmokers [106; 107]. Further, both of these studies found nega-
tive correlations between white matter integrity and addiction severity. Hudkins 2012
found a negative correlation between FA and addiction severity as measured by FTND,
cigs/day, and pack years [106], while Huang 2013 a negative correlation between FA
and physical dependence, hooked on nicotine checklist scores, and FTND (trending)
[107]. We find a positive correlation between cigarette dependence and white matter
integrity along the length of the cingulum anterior and body within smokers.
Prior fMRI studies have shown the anterior cingulate to be reactive to cigarette
smoking cues [146; 147; 148], affiliated with craving for cigarettes [148], and increased
craving has been related to increased potential for relapse. As our participants were
active smokers with no intent of cessation, perhaps this link to craving and continuation
to smoke could explain the findings in the anterior cingulum. Further, in this same
study those smokers that slipped from abstinence had decreased functional connectivity
between insula and dACC [148]. The authors suggested that this could potentially
reflect reduced top down control after exposure to smoking cues. Perhaps, the increased
structural integrity we see in our data reflects a compensatory effort in order to combat
this reduced functional connectivity with increased addiction severity.
3.4.3 Limitations
The small sample size of this study limited our power to detect significant effects of
either group or cigarette addiction severity. This limitation may, for example, explain
the lack of observed significant effects in the uncinate. Moreover, we were unable
to assess whether age, sex, ethnicity, or socioeconomic status moderated any of the
effects of smoking, as might be expected. Another limitation is the lack of information
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regarding other substance use among these participants. As such, cigarette smoking per
se may not entirely account for the effects that we observed. This issue is of particular
concern with regard to alcohol use, as heavy alcohol use is frequently associated with
heavy smoking [149], and heavy alcohol use is known to damage WM integrity in the
brain [150]. Knowing the alcohol consumption of our participants would have allowed
us to control for this potential confound.
3.4.4 Open questions
While we have documented WM integrity differences between smokers and non-
smokers, as well as differences among smokers that co−vary with addiction severity and
heaviness of smoking, whether these structural differences are consequences of cigarette
dependence or use, or preexisting features remains unknown. Prospective longitudinal
studies would shed light on this issue and will be essential for identifying anomalies in
brain structure that contribute to risk for cigarette dependence. Furthermore, while
we specifically investigated tracts implicated in episodic prospection, we did not ex-
plicitly test episodic prospection, or its ability to modulate decision−making, in these
participants. Future studies that investigate the relationship between WM structural
integrity in these tracts and the latter behavioral phenomenon may prove informative.
3.5 Conclusions
Consistent with our hypothesis, we found that smokers have decreased WM integrity
compared to nonsmokers in fiber tracts linking the medial temporal and frontal lobes,
specifically the bilateral fornix body and crus. Surprisingly, among smokers we found a
positive correlation between WM integrity and measurements of cigarette consumption
and addiction severity in the fornix, as well as in the cingulum, bilaterally. To our
knowledge, this is the first study in the field of cigarette dependence to use a DTI
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tractography analysis framework that provides tract specific and localizable results
along the length of a tract. Perhaps with specific and localizable results, we can begin
to clarify the mixed results from prior literature as to the relationship between cigarette
smoking and WM integrity. Further, a better understanding the role of the fornix and
cingulum in cigarette dependence may facilitate the development of novel therapies for
cigarette cessation. Prospective longitudinal studies are needed to determine if these
localized findings of white matter integrity are a result of cigarette dependence or if
they are pre−existing risk factors for cigarette addiction.
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CHAPTER 4
STRUCTURAL ALTERATIONS IN CIGARETTE SMOKERS:
IMPLICATIONS FOR COGNITIVE CONTROL, EPISODIC
PROSPECTION, AND DECISION−MAKING
1
4.1 Introduction
Cigarette smoking is the number one preventable cause of death, responsible for one
in five deaths in the US [3; 5] and one in ten deaths worldwide [1]. While it receives
less attention than other mortality factors, cigarettes cause more deaths than alcohol
use, illegal drug use, human immunodeficiency virus (HIV), motor vehicle accidents,
murders, and suicides combined [4; 5]. In addition to mortality, cigarettes induce
significant morbidity increasing the risk for coronary heart disease, stroke, chronic
obstructive lung diseases, and multiple forms of cancer [3; 5]. Along with the clear effect
of cigarettes on the body, the 7000 chemicals in cigarette smoke also impacts the brains
biology and function [151; 152; 153]. Moreover, the binding of nicotine to acetylcholine
receptors secondarily causes alterations in nearly all other neurotransmitter systems
in the brain [49], which in turn affects behavior and may contribute to the formation
cigarette dependence and addiction.
In the past decade, neuroimaging has been used to precisely assess living brain
1This chapter is in preparation for submission to NeuroImage Clinical
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structure in cigarette smokers. This work has demonstrated that compared to non-
smokers, smokers have decreased total brain grey matter volume and density, this gray
matter decrease has been localized to the frontal lobe, temporal lobe, insula, thala-
mus, and substantia nigra. Moreover, finer−grained investigations have identified less
grey matter among smokers in the anterior cingulate, prefrontal cortex (PFC), orbital
frontal cortex (OFC), parahippocampal gyrus, hippocampus, or hippocampus subfields
[113; 114; 110; 115; 116]. These decreases in gray matter volume/density in the frontal
lobe, temporal lobe, left PFC, hippocampus, subiculum, and presubiculum negatively
correlate with pack years [113; 110; 115]. Decreased cortical thickness was also found
in the anterior cingulate cortex, insula, total brain reward system, total frontal cor-
tex, and medial OFC, with the decrease in the OFC cortical thickness correlating with
cigarettes per day and pack years [117; 118].
Many of these areas altered in volume or thickness in cigarette smokers are a part of
the circuitry implicated in episodic prospection and decision−making, a circuit thought
to be important for addiction as a whole and cigarette addiction specifically. Previously,
we found that white matter integrity of tracts involved in the episodic prospection cir-
cuitry (cingulum, fornix and uncinate fasciculus) are abnormal in the brains of smokers
compared to nonsmokers, and within smokers white matter tract integrity changed as
a function of cigarette dependence severity and cigarette consumption (Chapter 3). In
this paper, we follow up these white matter findings with results on gray matter mor-
phometry via volume and thickness measurements in cortical and subcortical regions
served by the cingulum, fornix and uncinate tracts to see if they differ between smokers
and nonsmokers, and if the volumes and cortical thickness vary as a function of smoking
measures. Specifically we utilized FreeSurfer to analyze the cingulate cortex, orbital
frontal cortex, inferior frontal cortex, parahippocampal gyrus, hippocampus, thalamus,
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and amygdala. We hypothesized that the volume and thickness of our regions of inter-
est would be decreased in smokers compared to nonsmokers, and that within smokers
the volume and thickness would negatively correlate with measurements on cigarette
consumption (cigarettes per day and breath carbon monoxide (CO)) and cigarette ad-
diction severity as determined by the Cigarette Dependence Scale.
Participants
Mean / % SD (Range) Mean / % SD (Range) p-value
Age (years) 25.2 7.1 (19-40) 23.4 3.6 (19-29) 0.408
Sex (% Female) 55% 40% 0.692
Ethnicity (% Caucasian) 73% 47% 0.246
Education (years) 14.9 2 (12-18) 16.6 2.5 (12-21) 0.058
Smoking Measures:
Average Cigarettes/Day 13.2 6.5 (5-25)
CO concentration (parts/million) 12.5 11.3 (0-34)
Cigarette Dependence Scale 42.6 10.6 (27-59)
Age of Onset 17.5 2.4 (13-22)
Years Smoking 7.6 7.2 (1-25)
Smokers (n=11) Nonsmokers (n=15)
Table 4.1: Participant demographics and smoking measures. CO = carbon monoxide,
SD = standard deviation.
4.2 Methods
4.2.1 Participants
Participants were recruited from the University of North Carolina at Chapel Hill
(UNC) and surrounding areas by advertisement. Participants were healthy, right−handed,
native English speakers, 18−40 years old, without history of disorders of the nervous
system, current psychoactive medication use, or contraindications to magnetic reso-
nance imaging (MRI). Non−smokers reported no lifetime regular smoking; smokers
self−reported smoking ≥5 cigarettes per day. Participants provided written informed
consent as approved by the UNC Office of Human Research Ethics, and received mon-
etary compensation for participating.
We acquired high resolution magnetization prepared rapid gradient echo (MPRAGE)
T1−weighted images from 29 participants, 15 non−smokers and 14 smokers. Data from
n=3 smokers were excluded due to artifacts and low signal to noise ratio. Thus, all
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analyses reported here derive from 26 participants (15 non−smokers, 11 smokers). The
groups did not differ significantly by age, sex, ethnicity, or years of education (Table
4.1).
4.2.2 Measures
Smokers were instructed to smoke as usual on the day of the scan. Prior to scan ac-
quisition, participants completed questionnaires, and provided a breath carbon monox-
ide (CO) measurement. The questionnaires included a lab developed questionnaire
about smoking habits [138], and the Cigarette Dependence Scale (CDS, [55]). We
chose the CDS over the more frequently employed Fagerstrm Test for Nicotine Depen-
dence (FTND) as evidence demonstrates that the CDS performs better than the FTND
on measures of construct and predictive validity [53; 54].
4.2.3 Image Acquisition
Data were acquired on a 3T Siemens Allegra head−only MRI scanner (Siemens
Medical System, Erlangen, Germany) with a standard Siemens 8−channel phased ar-
ray head coil. A whole−head, high−resolution T1−weighted MPRAGE images was
obtained from each participant (TR/TE/T1=1750/4.38/900 ms; flip angle=8◦; 25.6
cm FoV; 256 208 in-plane matrix, 160 axial slices, voxel resolution = 1.0 mm3).
4.2.4 Image processing
The publicly available FreeSurfer version 5.3 (http://surfer.nmr.mgh.harvard.
edu/) was utilized to assess bilateral regional cortical and subcortical volumes, and
regional cortical thickness [85; 86; 87; 88; 89; 90; 91; 92; 93; 94; 95; 96; 97]. Measure-
ments were acquired from the 2009 Destrieux Atlas in FreeSurfer for regions important
for episodic prospection decision−making (Figure 4.1). Specifically we analyzed the 42
cortical and 6 subcortical regions composing the cingulate cortex, orbital frontal cortex,
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Figure 4.1: Cortical regions investigated that are implicated in episodic prospection
and decision−making. Regions from the 2009 Destrieux atlas composing the cingulate,
the inferior frontal gyrus, and the orbital frontal cortex projected on an average inflated
brain created from our participant sample. Tan areas were not investigated, and the
black region represents the medial wall. These cortical regions, and subcortical regions
consisting of the hippocampus, thalamus, and amygdala were investigated bilaterally.
inferior frontal cortex, parahippocampal gyrus, hippocampus, thalamus, and amygdala
bilaterally. Right and left structures were tested separately for cortical volume (ml)
and cortical thickness (mm). Cortical measurements from the temporal lobe were not
considered due to the poor surface construction in this location resulting from low T1
intensities.
4.2.5 Statistics
For between group comparisons, we used Students t−tests for continuous measures,
and χ2 tests for dichotomous variables. Volume and thickness estimates were exported
to SPSS (version 21; SPSS Inc., Chicago, IL, USA) and analyzed via multiple re-
gression with the first model evaluating the effect of total intracranial volume (ICV)
and age, and the second group evaluating total intracranial volume, age, and group
(smokers vs non−smokers). There was no difference in ICV between smokers and
non−smokers. For within smokers analysis we calculated partial correlation Pearson
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Group Analysis (n = 26)
ROI p β
Left Hippocampus 0.021 -331.149 -588.315 -76.193
Left Posterior Ventral Cingulate Gyrus Thickness 0.020 -0.226 -0.389 -0.060
Right Middle Posterior Cingulate Volume 0.043 400.788 37.342 743.837
Smoker Analysis (n = 11)
ROI
Cigarettes/Day p r
Left Amygdala 0.023 -0.74 -0.977 0.011
Right Pars Orbitalis Gyrus Thickness 0.018 -0.757 -0.984 -0.121
Right Pars Triangularis Gyrus Thickness 0.001* -0.889 -0.994 0.277
CO p r
Right Pars Orbitalis Gyrus Volume 0.042 -0.685 -0.972 0.119
Right Pars Orbitalis Gyrus Thickness 0.001* -0.895 -0.991 -0.629
Right Pars Triangularis Gyrus Thickness 0.035 -0.702 -0.973 0.755
Right Orbital Lateral Sulcus Thickness 0.015 -0.77 -0.977 -0.515
CDS p r
Right Pars Triangularis Gyrus Thickness 0.019 -0.753 -0.99 0.558
Left Pars Triangularis Gyrus Thickness 0.004 -0.841 -0.98 -0.15
Left Middle Anterior Cingulate Thickness 0.013 -0.782 -0.979 -0.499
95% C.I.
95% C.I.
95% C.I.
95% C.I.
Table 4.2: Significant results from cortical and subcortical volume, and cortical thick-
ness analysis. Significant results split by between group and within smokers findings.
with the smokers analysis divided by measurement of cigarette consumption or de-
pendence. P−values presented here are the non−FDR adjusted figures, with the *
designating the two results that survived correction. ROI = region of interest, C.I. =
confidence interval, CO = carbon monoxide, CDS = cigarette dependence scale.
coefficients in models for demographic factors, smoking habit intensity measures and
FreeSurfer measurements, as implemented in SPSS. To eliminate concerns regarding
violation of parametric test assumptions, bootstrapping procedures (n = 10,000 resam-
ples) were used in tests of statistical significance. Correction of p−values for multiple
comparisons using the false discovery rate (FDR) procedure [154] was carried out in R
(http://www.R-project.org). The threshold for statistical significance was p < .05.
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Figure 4.2: Significant findings when comparing smokers to non−smokers. A. In sub-
cortical regions, smokers were found to have decreased volume of the left hippocampus
compared to nonsmokers. B. Cortical thickness/volume findings portrayed on an av-
erage inflated brain created from our sample population. Brain images relate to the
plot positioned directly below. Smokers were found to have a thinner cortex in the
left posterior ventral cingulate than nonsmokers, and a greater cortical volume than
nonsmokers for the right middle posterior cingulate. Plots demonstrate the range of
volumes for each group, the median, and the first and third quartile. Tan areas were not
investigated, dark blue areas were investigated but non−significant, significant areas
are shades of pink.
4.3 Results
Visualization of all regions analyzed can be seen in Figure 4.1. Significant results
from all analyses are located in Table 4.2. Those p−values that survived FDR correction
at a 0.05 threshold are indicated with an asterisk. For result visualizations, brain regions
that are dark blue indicate investigated regions that were not significant. Significant
regions are represented by different shades of warm colors (pink, red, orange, yellow).
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4.3.1 Comparison of smokers to non−smokers
Smokers were found to have decreased volume in the left hippocampus (Figure 4.2A),
and decreased cortical thickness in the left posterior ventral cingulate gyrus compared
to nonsmokers (Figure 4.2B left). However, the right middle posterior gyrus and sulcal
volume was greater in smokers than nonsmokers (Figure 4.2B right).
4.3.2 Within smokers analysis
Findings within smokers by smoking variable of interest can be seen in Figure 4.3.
For all smoking variables investigated, negative correlations were found with regional
volumes and thicknesses as displayed on an inflated average brain in Figure 4.3A.
Cigarettes per day
Right inferior frontal gyrus regions, the pars triangularis and pars orbitalis, are
decreased in thickness with increasing numbers of cigarettes per day. The left amygdala
volume also shows a negative correlation with cigarettes consumed daily (Figure 4.3B).
Breath carbon monoxide concentration
Inverse correlations are also found when looking at the effect of carbon monoxide
(CO) concentration. Cortical thickness decreases as a function of increasing CO in the
right pars triangularis gyrus, right pars orbitalis gyrus, and right lateral orbital sulcus.
Cortical volume also negatively correlated with CO in the right pars orbitalis gyrus
(Figure 4.3C).
Cigarettes Dependence Scale scores
With increasing addiction severity as measured via the CDS, cortical thickness de-
creased in the right pars triangularis gyrus, left pars triangularis gyrus, and left middle
anterior cingulate gyrus and sulcus (Figure 4.3D).
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Figure 4.3: Volume and thickness findings within smokers and how they correlate with
measurements of cigarette consumption and cigarette dependence severity. A. Cortical
thickness and volume findings in smokers projected on an inflated average brain created
from the sample population. Left most brain displays the right pars triangularis (red),
pars orbitalis (yellow), and lateral orbital sulcus (bright orange). The second brain
shows the left pars triangularis in red. The third image is an anatomical MRI high-
lighting the amygdala. The right most brain displays the left middle anterior cingulate
in dark orange. B. Correlations between cortical thickness/volume and subcortical vol-
umes, and cigarettes per day. C. Correlations between cortical thickness/volume and
breath carbon monoxide (CO). D. Correlations between cortical thickness/volume and
Cigarette Dependence Scale scores. All plot outlines are colored to match their corre-
sponding cortical or subcortical brain region. The correlation coefficients and p−values
displayed are from the partial correlation analysis with bootstrapping.
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4.4 Discussion
Overall, smokers were found to have decreased volume and thickness in regions
important for episodic prospection and decision-making than non−smokers, and within
smokers cortical thickness and volume was found to decrease with increasing cigarette
consumption and dependence.
4.4.1 Structural differences between cigarette smokers and non−smokers
Consistent with our hypothesis, smokers had decreased volume in the left hippocam-
pus and decreased cortical thickness in the left posterior ventral cingulate gyrus com-
pared to nonsmokers. Both the hippocampus and cingulate are part of the circuitry
required for episodic prospection and decision−making. Decreased volumes and cor-
tical thickness in these areas could translate to reduced functionality of these areas,
rendering smokers with an inability to truly prospect and appreciate how choosing de-
layed reward could be better than the instant gratification of smoking now. Decreased
hippocampal volume has been previously documented in cigarette smokers, and this
decrease in volume likely plays a role in the cycle of cigarette addiction [115]. Contrary
to our hypothesis and adding breadth to the literature, we also found an increase in
volume in the right middle posterior cingulate cortex of smokers compared to nonsmok-
ers, a region important for emotional awareness. Increases in volume could result from
increased neuronal connections, increased astrocytes, inflammation, and edema. How-
ever, as this finding was barely significant it is likely that with a larger sample size this
effect would not have been observed, and thus it should be interpreted with caution.
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4.4.2 Grey matter thickness and volume negatively correlates with cigarette
consumption and addiction severity
Within smokers, most of the findings reside in the right hemisphere and particularly
within the right inferior frontal gyrus (IFG) regions, the pars triangularis and pars
orbitalis. While we did not detect a difference by group for inferior frontal gyrus regions,
a recent study with a larger sample size did detect this effect of group [113]. Of the
regions displaying inverse relationships with measures of cigarette dependence, only the
right pars triangularis cortical thickness negatively correlated with all three smoking
measures. This region showed decreased cortical thickness with increasing number
of cigarettes, increasing CO concentration, and with increasing addiction severity as
measured with the CDS. The left pars triangularis cortical thickness also correlated
negatively with Cigarette Dependence Scale scores. This is the first study to show
cortical thickness measurements within smokers to correlate with scores on the CDS,
as most other smoking studies default to the FTND to measure cigarette addiction
severity.
The region with the second most number of relationships was the right pars orbitalis,
whose cortical thickness negatively correlated with cigarettes per day and CO, and its
volume with CO. In addition to these two regions of the inferior frontal gyrus, other
regions found to have significant negative correlations were the left amygdala volume
(cigs/day), right lateral orbital sulcus thickness (CO), and left middle anterior cingulate
thickness (CDS). Together, all of these regions are important for cognitive control,
resisting the desire to make impulsive choices, processing of emotional stimuli, episodic
retrieval, and decision−making [155; 156; 157; 158; 159; 160; 161; 162].
Decreased cortical thicknesses and volumes in these areas may lead to decreased abil-
ity of these regions to perform their functions, leading to more impulsive choices and
impaired decision making. Functional studies where smokers are asked to purposefully
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resist an immediate reward for a delayed reward show hyperactivity, or increased re-
cruitment in these areas compared to normal controls [160]. This increased recruitment
suggests a deficit in function, where more neurons are required to perform the same
cognitive task that normal individuals require less neurons to do. Impaired function in
these regions is also supported by the definition of cigarette addiction, where behavior
is characterized by the continued preference for immediate gratification of continuing to
smoke even in the face of negative consequences. Additionally, reduced functionality of
these regions was also shown through hypoactivity of the anterior cingulate (ACC), infe-
rior frontal gyrus, and posterior cingulate (PCC) on an affective stroop task measuring
reactivity to negative emotional cues [163]. The authors deduced that this hypoactiv-
ity in the ACC, IFG, and PCC supported the notion that chronic cigarette use may
handicap inhibitory control and conflict resolution of emotionally salient distractors,
and that this reduction may lead to the recruitment of additional brain regions during
negative emotional decision making. Further, the direction of the effect suggested that
smokers were biasing their attention away from negative cues, thereby reinforcing the
use of cigarette through increased affect.
While most findings within smokers also did not survive FDR correction, the con-
sistency of the findings across measures of cigarette consumption and addiction severity
makes these effects more believable and likely to be found in the case of a larger sample
size. Some relationships within smokers also trended towards significance such as the
left hippocampus volume (CO, p = 0.052, r = −0.662), right pars opercularis thickness
(CDS, p = 0.052, r = −0.662), and right fontal inferior sulcus thickness (CO, p =
0.052, r = −0.661). Areas found to be different in smokers and nonsmokers, the left
posterior ventral cingulate gyrus thickness and right middle posterior cingulate volume
did not significantly correlate with cigs/day, CO or CDS in smokers, which means other
smoking variables must contribute to the difference between groups.
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4.4.3 Limitations
With a small sample size, this study has clear limitations in terms of the general-
izability of the findings. The results reported here will serve as hypotheses for future
larger imaging studies. Further, analysis of cortical regions within the temporal lobe
was impaired due to low signal contrast, prohibiting from investigating all cortical re-
gions important for this circuitry of episodic prospection and decision making. Also
as a cross sectional analysis, we can not know whether the findings reported here are
caused by cigarette smoking, or are pre−existing differences in the brain structure of
individuals that make them more likely to become dependent on cigarettes. However,
animal literature demonstrates that exposure to the components of cigarette smoke
causes neuronal cell death through direct toxicity, oxidative stress, and increased in-
flammation [151; 152; 153]. While this study specifically examines regions important for
episodic prospection and decision−making, it does not explicitly test whether episodic
prospection is impaired in cigarette smokers and whether an impairment correlates with
cigarette consumption and addiction severity. Results from this study should be used
as hypotheses in a larger imaging study directly investigating these questions.
4.4.4 Conclusions
The present findings are in line with the existing body of literature looking not
only between smokers and non−smokers, but within smokers as a function of addiction
severity. Overall our findings support the hypothesis that gray matter in brain regions
implicated in episodic prospection and decision−making are decreased in smokers com-
pared to non−smokers, with regional gray matter thicknesses and volumes negatively
correlating with measures of cigarette habit intensity.
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CHAPTER 5
DISCUSSION
5.1 Aim of this dissertation
Through this study we sought to determine if there are any structural differences
between cigarette smokers and non−smokers in the circuitry important for episodic
prospection and decision making through the use of DTI and sMRI analysis. Further,
we investigated within smokers whether there were any structural changes in this cir-
cuitry that correlated with measurements of cigarette consumption (cigarettes per day
and breath carbon monoxide), and addiction severity as measured with the cigarette
dependence scale (CDS). Specifically we studied the white matter tracts the cingulum,
fornix, and uncinate, and the grey matter regions that these tracts connect, namely re-
gions of the medial temporal lobe and the prefrontal cortex. Our hypotheses were that
smokers would have decreased white matter structural integrity in the tracts bilaterally
compared to nonsmokers, and that the brain regions served by these tracts would have
decreased volume and thickness in smokers compared to non−smokers. Within smok-
ers, we hypothesized that with increasing cigarette consumption and addiction severity
there would be decreased white matter integrity, and decreased regional grey matter
volume and thickness.
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5.2 Brief results summary
DTI analysis provided findings within the fornix and cingulum, while sMRI anal-
ysis complemented the DTI investigation with results in the hippocampus, cingulate,
amygdala, OFC, and inferior frontal gyrus. All of these regions are implicated in the
circuitry important for episodic prospection, cognitive control, and conflict resolution
in decision−making [155; 156; 157; 158; 159; 160; 161; 162].
Group differences were found between the two methods that provide strong evi-
dence supporting the assertion that cigarette smokers have altered circuitry impor-
tant for episodic prospection, and decision−making. While findings of decreased white
matter integrity in the fornix crus and body of smokers is new for the field studying
cigarette dependence, the result showing decreased left hippocampal volume in smok-
ers compared to non−smokers falls in line with prior studies [115]. Both group results
are in line with our hypothesis that smokers would demonstrate white matter of lower
integrity and decreased grey matter volume.
However, findings within smokers provide an interesting story for how white and
grey matter integrity relate to measurements of cigarette consumption and addiction
severity. Within smokers, with increasing cigarette consumption and dependence we
measured increased white matter integrity or organization within the fornix and cin-
gulum bilaterally. Both of these findings are new for the field, and are contrary to our
hypothesis for the effect of smoking variables on white matter integrity. While prior
DTI literature provides mixed results as to the direction of group effect on white matter
integrity, almost all studies to find a relationship between white mater integrity and
measurements of smoking consumption and dependence have demonstrated a negative
relationship [104; 110; 106; 107]. However, as pointed out in the Smoking DTI Chap-
ter, all prior DTI smoking literature has relied on less specific and localized analysis
techniques for the measurement of diffusion parameters than what was employed in
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this dissertation. With along the tract analysis of diffusion becoming the gold stan-
dard for DTI investigation, hopefully these positive correlations will be replicated by
future studies. Either way, along the tract analysis provides a more realistic picture of
diffusion in individual fiber tracts, and a better insight to the potential differences in
neurobiology among smokers. These findings provide interesting hypotheses to follow
up on in future work.
While DTI analysis found a positive correlation between white matter integrity and
measurements of cigarette consumption and addiction severity, sMRI analysis found
negative correlations between these same measures and findings of brain region cortical
thickness and volume within smokers. Structures demonstrating decreased volume and
thickness were two regions of the inferior frontal gyrus (pars triangularis and pars or-
bitalis), lateral orbital frontal sulcus, middle anterior cingulate, and amygdala. These
regions are all functionally related to the weighing of emotional features of a decision,
impulse inhibition, and cognitive control [155; 156; 157; 158; 159; 160; 161; 162]. A
previous study found that chronic cigarette smoking is associated with reduced func-
tionality of the inferior frontal gyrus in inhibitory control, and the anterior cingulate in
conflict resolution when an emotional distractor is present [163]. A separate study also
came to the same conclusion that the inferior frontal gyrus showed decreased function-
ality in cigarette smokers compared to nonsmokers, and it demonstrated this decrease
in function through increased activation when smokers tried to resist an immediate
small reward to hold out for a delayed larger reward [160]. The authors suggested that
this increase in activation could reflect the need for increased neuronal recruitment to
perform the same task a non−addicted individual would require less neuronal activity
to perform.
Decreased cortical thickness and volumes in these regions with increasing cigarette
use, as well as addiction severity suggests that cigarette smoking may cause damage to
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neurons and result in cell death. Cigarette smoke is composed of over 7000 chemicals,
many of which are known carcinogens and toxins [3]. Besides through direct toxicity
of cells from the many chemicals in cigarette smoke, this chemical milieu also leads
to increased leakiness of the blood brain barrier, oxidative stress, and upregulation of
inflammatory cytokines, all of which can cause further secondary damage to neurons
[153; 152; 151]. There is work showing that those with a history of cigarette smoking
lose volume in the pars triangularis, pars orbitalis, lateral orbitofrontal cortex, posterior
cingulate gyrus, and isthmus of the cingulate gyrus at an increased rate compared
to non−smokers [164]. Indicating, that just a history, not even current smoking, is
associated with long term changes in the brain that lead to increased rate of cortical
atrophy in regions important for memory, impulse control, and decision−making.
Thus, what our results may imply is that as cigarette consumption and dependence
increase, the exposure to the components of cigarette smoke may cause cellular damage
and ultimately neuronal cell death as visualized by the decrease in gray matter thickness
and volume. This cell death would lead to a loss of axons composing the white matter
tracts that serve to connect this circuitry for episodic prospection and decision−making.
With a loss of cells, there are less cells in these regions to perform their necessary
function, likely resulting in a functional deficit. As this insult likely is chronic and
occurs over a long period of time, the brain may try to structurally compensate for
this loss of cells by strengthening or reorganizing the connectivity between these brain
regions, thus enhancing the white matter integrity of these fiber bundles in hopes to
rescue some functionality and ultimately behavior. Alternatively, these differences in
brain region thickness and volume could equally indicate structural aberrations that
predispose individuals to become cigarette dependent and to smoke to a certain extent,
or a mixture of structural predisposition and damage caused by smoking.
84
5.3 Circuit components with significant results in both DTI and sMRI
analysis
5.3.1 Group differences in the fornix and hippocampus
In the DTI analysis, smokers were found to have decreased structural integrity in
the fornix crus and body bilaterally compared to nonsmokers. This finding relates to
the sMRI result that smokers have smaller left hippocampal volume than non−smokers.
While the hippocampus is composed of much more than the cells that create the fornix,
the fornix is the white matter projection of the hippocampus that allows it to com-
municate with other regions of the brain as it orchestrates the formation and recall of
memory. Decreased volume in the hippocampus is typically taken to represent the loss
of neurons through cell death, or a loss of neuropil. With loss of neuron cell bodies, the
fiber tract of the fornix could be affected and the integrity decreased if the cells lost
were those that form the fornix. If this is the case though, the question is then why is
the decrease in white matter integrity only in the fornix crura and body? Specifically,
why is it not also in the fimbria, the part of the fornix still housed in the hippocampus?
The crura is the location on the fornix where there are commissural fibers that form
a web between the two fornix crus, serving as the main form of communication between
the left and right hippocampi, and the fornix body is the only section of the fornix where
the left and right are together as one tract. Whether this anatomical feature could have
something to do with the decreased white matter integrity is unknown. Perhaps these
fibers that allow for inter−hemispheric communication are particularly vulnerable to
possible insult that may be caused by cigarette smoking, or this region could represent
a structural difference that makes individuals more likely to become smokers. Perhaps
a decreased structural integrity in this region of the fornix impairs cross referencing
between hippocampi and thus leads to cigarette smokers only best appreciating the
now with a decreased ability to access the past or to prospect into the future.
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To our knowledge this is the first time that the fornix has been analyzed in cigarette
smokers. However, previous work has found decreased hippocampal volume in smokers
compared to non−smokers, backing up the validity of our data and suggesting that this
finding in the fornix is worth following up on in future investigations [115]. This paper
also found that increased hippocampal volume, particularly on the left, corresponded
to better learning and memory. This would make sense since smokers are known to
perform more poorly on tasks assessing learning and memory [165; 166]. Damage to
either the fornix or hippocampus would impair the use of memory in decision−making,
a process important for daily life and specifically behavioral choices such as the choice
between smoking now or abstaining for future improved health.
5.3.2 How measurements of smoking consumption and severity affect the
cingulum and cingulate
For both measures of cigarette consumption (cigarettes/day and exhaled CO) and
cigarette dependence scale scores, positive relationships were found with white matter
integrity bilaterally. Unlike findings in the fornix, for the cingulum, the largest bilateral
effect is found with exhaled CO, particularly for the anterior cingulum. This may be
due to the fact that the cingulum may be more affected by the biological cascade of
neurotransmitters caused by the main addictive component in cigarettes, nicotine. The
cingulate cortex, particularly the anterior cingulate, has a large amount of nAChRs
which nicotine can bind and alter behavior via long term potentiation of glutamate
signaling, which would could contribute to increased tract stability or organization
with increased smoking.
While the white matter tract findings in the cingulum related positively with mea-
sures of cigarette consumption and addiction severity, grey matter cortical thickness of
the left middle anterior cingulate thickness negatively correlated with CDS scores. Here
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this decrease in thickness could represent cell death, and the increased white matter in-
tegrity of the cingulum feeding this region of the cortex may represent a reorganization
of the tract in order to functionally compensate for the decrease in neurons available
to perform the same function. Much of the fMRI literature in smokers focuses on the
anterior aspect of the cingulate cortex and its involvement in responses to cigarette and
smoking cues. This misallocated attention to cigarettes cues is thought to play a role
in cigarette craving, and to ultimately be what leads to relapse during a quit attempt.
The role of the anterior cingulate in emotional valuation of cues, and top−down inhi-
bition is altered in cigarette smokers. The structural changes in cortical thickness and
a restructuring of the white matter bundle for compensation, may lead to this altered
behavior.
5.4 Implications of findings on clinical practice
Knowing that these areas necessary for episodic memory and prospection are struc-
turally deficient in smokers compared to non−smokers is important and has potential
implications for behavior and treatment. The ability to draw upon past experiences
and to realistically weigh the future consequences of choices are skills utilized every day
when making decisions about how to lead our life. Smokers have already been shown to
perform less well than non−smokers on measures of episodic memory, and our findings
provide possible structural explanations for this behavioral difference [165]. The abil-
ity to think in a detailed manner about yourself in the past and future is particularly
pertinent when enrolled in cognitive behavioral therapy, one of the main strategies of
treatment available to cigarette users when looking for help in quitting smoking. If the
circuit required to perform the tasks in therapy are damaged in cigarette smokers either
prior to smoking or as a result of smoking, then it is no surprise that the success rate of
cessation is so low when long term end points are evaluated (a year or more). Perhaps
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strategies or exercises to improve episodic prospection could be beneficial before the
initiation of cognitive behavioral therapy. Although, since individuals with cigarette
dependence also demonstrate low self−control, it is unlikely that they will stick with a
training regimen prior to starting treatment.
Which leads into our findings within smokers that let us know that regions of the
brain required for impulse control, emotional salience of cues, and conflict resolution in
decision−making are important for and have strong relationships to the heaviness of
smoking, as well as the severity of the addiction. These results give structural support
to behavioral findings demonstrating that cigarette smokers behave more impulsively
than normal controls on measures of impulsivity, such as the delay discounting (DD)
task [167; 168; 169; 170; 171; 56; 172]. Further, the level of impulsivity within smokers
on the DD task has been shown previously to positively correlate with higher smoking
rates [173; 174; 131; 171], an earlier age of smoking onset [175], and a shorter time to
relapse after a quit attempt [176; 177].
5.5 How our findings in cigarette smokers relate to other forms of addiction
It is cautionary to compare structural brain alterations across addictions, because
each substance will likely affect the brain differently. However, while some of our re-
sults could reflect the brains exposure to cigarette smoke specifically, it is likely that
our findings are also in part a result of the process of addiction formation and mainte-
nance, or biological predisposition to addiction disorders. These latter two components
may have shared features between addiction disorders. Some of these shared features
could represent genetic predispositions, as most addiction disorders have some genetic
influence. While the level of heredity will vary between substances and ethnic groups,
it is likely that the heredity will manifest in several domains. For cigarette dependence,
the overall heredity is 59%, but the smoking initiation (50%) and cigarette addiction
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maintenance likely have separate heritability [178]. Prior studies in alcoholism have con-
sistently found decreased FA in alcoholics, and decreased grey matter volumes [179].
DTI analysis is new in gambling, but a recent study did show decreased FA in the
corpus callosum compared to controls [180], however this effect may in part be due to
alcohol consumption. This highlights the important point that most addiction disor-
ders are comorbid with other addiction disorders, and with psychiatric disorders. Care
must be taken in the data acquisition and analysis to fully control for these confounds.
5.6 All things considered
Together, both the DTI and sMRI analysis performed in this dissertation found
results that support the hypothesis that the circuitry implicated in episodic prospection
and decision−making is structurally altered in individuals that are cigarette dependent.
These structural alterations may contribute to the behavioral impulsivity displayed by
cigarette smokers, both in their performance on the delay discounting task and in the
real life decision to continue smoking.
The utilization of along the tract DTI analysis furthers our understanding of the
neurobiology of this disease. Unlike in prior literature where broad statements were
made about entire tracts, using along the tract analysis plainly shows us that changes
are not uniform in direction or magnitude along the length of the tract. This makes
biological sense as the tracts traverse the brain and connect various cortical and sub-
cortical regions, they enter and are involved in multiple microenvironments that will
differ in vulnerability to damage from cigarette smoking.
5.7 Novel components of this study
The analyses performed for this dissertation have several novel components that add
to the field study cigarette dependence. The prior DTI literature investigating cigarette
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smokers has reported inconsistent results. One reason for these inconsistencies may be
the analysis methods used which make it impossible to have localized, tract specific
results. In hopes of providing clarity, this study is the first in the cigarette smoking
field of research to use an along the tract tractography based DTI analysis. This style
of analysis makes it possible for the first time in the smoking literature to analyze
diffusion at each millimeter along a singular fiber bundle. This study is also the first
to use our along the tract UNC−Utah NA−MIC DTI Fiber Analysis Framework in an
adult study sample. While this framework existed prior to my completion of 2 of this
dissertation, it was present in separate scripts available for use only in command line
format. Now, there are graphical user interfaces for each step of the process, allowing
for a smooth analysis of diffusion data for any non−technical user. Further, prior to
this study, all of previous application of the tools in our framework were in neonate
and infant brain development studies. This study demonstrates that this workflow can
be used for the study of adult data, and the framework is now freely available to the
entire neuroscience field.
As along the tract analysis of DTI data is a new technique, we are also the first
in the cigarette dependence field to pair this DTI analysis style with sMRI analysis.
Combining imaging modalities is a powerful technique that enables a more clear per-
spective as to the biology being observed in the brain, by collecting information on
both the white and gray matter. While the DTI and sMRI analysis provide different
kinds of information on brain structure, looking at the two information types together
helps in determining the full picture. Through multimodal analysis, we were able to
uncover a new interesting story that may provide structural evidence for known behav-
ioral differences between smokers and non−smokers, and among those who are cigarette
dependent.
Within the cigarette dependence literature, this is the first study to investigate the
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fornix, and thus our findings in this tract adds breadth to the literature and provides a
new region of the brain worthy of further investigation in cigarette dependence. Lastly,
this is the first study to our knowledge to correlate white and grey matter structural
findings with the Cigarette Dependence Scale as a measurement of cigarette addiction
severity. Most prior studies rely upon the FTND to measure addiction severity, so these
analyses provide support for the use of the CDS in future studies.
5.8 Limitations
The limitations to this dissertation are many. The first and largest limitation being
the small sample size for analysis that limits the generalizability of the results, and
requires replication. While our sample size is similar to other studies published in the
literature, we acknowledge that there are many factors involved in cigarette dependence
that were not investigated directly, or controlled for in this study due to limited power.
Ideally we would like to have considered family history of cigarette dependence, common
polymorphisms in important enzyme genes that regulate dopamine levels such as DAT
and COMT, as well as nAChR SNPs that could contribute to addiction disorders. We
did not collect information on the use of other legal and illegal substances, which is an
important detail to consider in cigarette smokers as alcohol consumption and the use
of other drugs is often comorbid with cigarette dependence. Other studies also often
look at how age of onset affects cigarette addiction severity, and have found those who
start smoking at an earlier age to be more impaired on measures of working memory
[? ]. While we did not look at age of onset in our study, we did control for participant
age, which positively correlated with age of onset for the DTI study, but not the sMRI
analysis. Age of onset did however negatively correlate with craving prior to the scan,
which highlights yet another facet of addiction (craving) that we would like to further
investigate. Due to these limitations, our results are preliminary and will form the basis
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for future scientific inquiry within the lab.
Further, the data analyzed here were collected within a study thats main focus was
fMRI analysis, thus the DTI and sMRI acquisition sequences, and field of views were
not optimal for these methods of analysis. For example, there were several regions of the
brain that could not be analyzed in the structural analysis with FreeSurfer as the signal
intensity was too low in regions of the temporal pole and superior frontal and parietal
cortices. This limited our analysis of the circuitry involved in episodic prospection
and decision−making as we could not interrogate the temporal lobe cortical regions
for effect of group or cigarette consumption and dependence. While this limited the
analysis in this dissertation, it did allow us to recognize the situation, and to adjust
our DTI and sMRI protocols for other studies in the lab where data acquisition was
ongoing or still in the planning stages. So through this dissertation, our lab will now
have better DTI and sMRI acquisition sequences going forward, and frameworks with
which to analyze the data.
5.9 Remaining questions and future studies in an ideal world
What is not known, and what has not been shown in the literature is whether these
deficits and deviations from normal structure and function are prior existing differences
in individuals that make them more susceptible to trying and becoming dependent on
cigarettes, or are these deviations in structure and function caused by the addiction
to cigarettes either through insult or by altering the neurobiology and connectivity
landscape, or both? In order to know the answer to this question, longitudinal studies
are needed to analyze the brains of individuals before they begin smoking, see which
individuals choose to smoke, which ones become dependent, and how the amount and
time of smoking changes the structural and functional integrity of their brain.
Cognitive behavioral therapy may help in deflecting impulsive choice by distracting
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attention from the immediate reward and purposefully placing attention on the de-
layed reward. Episodic prospection is a key component of cognitive behavioral therapy.
Thus, while this study was motivated by two papers demonstrating that the use of
episodic prospection during the delayed reward discounting tasks could decrease delay
discounting/impulsive choice in healthy controls, this hypothesis remains to be tested
in cigarette smokers.
An ideal cross sectional study would be to recruit a large number of cigarette de-
pendent individuals, and an age and sex matched group of never−smokers ages 18−40.
Participants should be right handed, non−pregnant, have no contraindications to MRI,
no psychoactive medication use, or any serious medical illness. Non−smokers should
be defined as never−smokers, and smokers would be defined as consuming 15 or more
cigarettes per day for the past year. there would be two study sessions, where in the
first session participants will come to the lab and fill out questionnaires and self−report
measures assessing cigarette consumption, dependence and other variables often comor-
bid with smoking. These measures would include the Cigarette Dependence Scale, the
Fagerstrm Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Question-
naire, a cigarette craving questionnaire, a family history of smoking questionnaire,
an IQ measurement, Barratt Impulsivity Scale, AUDIT, Drug Use Inventory, Beck
Depression Inventory, State−Trait Anxiety Inventory, BMI, and Hollingshead Socioe-
conomic Status. Importantly, also during this first session they will fill out a calendar
of important events coming up in their life for the next year and rate each event on
personal relevance, arousal, and valence. It is from these events that we will construct
an episodic prospection version of the delayed discounting task. This first session will
conclude with a training session in the mock scanner where participants can be exposed
to the normal delay discounting task, and their personal discounting rate will be as-
sessed. A saliva sample will be collected at both visits to ensure at least one quality
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sample and ample amount of material for genetic analysis of various COMT, VAT, DA
receptor, and nAChR SNPs implicated in cigarette dependence. The second session
will require an exhaled CO measurement prior to scanning, a practice round of the
normal delay discounting task, and then performance of the experimental trials while
within the scanner. The experimental delay discounting task will include the normal
condition trials of Want, Dont Want, Sooner, and Larger, as well as an Episodic Want
condition. The normal and episodic want conditions will occur for the same number of
trials. The episodic want conditions will appear the same as the want condition options
with the addition of an episodic tag from that participants calendar of events for the
appropriate timing of the delay option. This experiment would allow us to explicitly
test whether episodic prospection changes the delay discounting behavior of smokers
compared to non−smokers, and if the behavior within smokers varies by any of the
collected questionnaires relevant for cigarette dependence.
This ideal study could be adjusted for the gold standard of longitudinal analysis
if recruitment of participants occurred at about age 10, prior to the development of
cigarette dependence. Recruitment would be established on baseline behavioral im-
pulsivity as measured by the normal delay discounting task. We would want an even
amount of low and high discounters to assess whether this measure of behavioral im-
pulsivity is something that exists prior to cigarette dependence, and that predisposes
individuals to trying cigarettes and becoming dependent. We would also want an even
split of individuals with and without family history of cigarette smoking. Cigarette de-
pendence has been show to be 75% heritable, thus having an equal representation of the
genetically predisposed and normal individuals will allow us to make statements of her-
itability and how it interacts with the use of episodic prospection to alter behavioral
impulsivity [181]. Anatomical, DTI, resting state functional, and delay discounting
task fMRI imaging would be acquired at each test visit, along with the questionnaires.
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These acquisition sequences would be optimized for high quality data for each type of
image, and include a field of view containing the entire head of each participant. The
state of each participants acquisition would also be quality controlled in real time to
ensure that each acquisition meets the standard of an acceptable image. This would
require a lengthy scan time, but in this fantasy, funds are limitless and participants
stay still for long periods of time. Visits would be at intake (10 yrs old) and then every
five years afterward until age 60, with a total 11 visits. This span of time aims to catch
individuals before exposure to cigarettes, during the years of cigarette experimentation,
the transition to dependence, the years where quit attempts occur and fail, the time
around 40 yrs old when quit attempts start to achieve a better rate of success, and
then twenty years post quit to see if any structural or functional insults from cigarette
smoking resolve with cessation.
5.10 In conclusion
Through the study of both DTI and sMRI data we found smokers to have de-
creased integrity in brain regions implicated in episodic prospection, decision making,
and impulse control. These findings give structural support to behavioral literature
documenting that smokers show decreased impulse control, perform impulsively in de-
cision making tasks, and perform poorly on measures of episodic memory. Prospective
studies are needed to know what comes first, the structural aberration or the addiction,
but using our new method for DTI analysis can help provide more detailed results for
diffusion along individual fiber bundles. These more specific and localizable results
will help in better understanding the neurobiology of cigarette dependence. Through
a better understanding of the neurobiology of cigarette addiction, we can create more
effective therapies that smokers would want to use to aid in their cessation attempts.
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